Filip Štrbac – Antibiotics – Best Researcher Award

Published on by Infectious

Filip Štrbac - Antibiotics - Best Researcher Award

University of Belgrade - Institute for Multidisciplinary Research - Serbia

AUTHOR PROFILE 

ORCID
GOOGLE SCHOLAR

EARLY ACADEMIC ROOTS 🌱

Dr. Filip Štrbac’s academic journey in the field of veterinary medicine began with distinction and purpose. Born in Novi Sad, Serbia, his natural aptitude for science was evident during his time at “Jovan Jovanović Zmaj” High School, where he pursued natural sciences and mathematics. This foundation led him to the Faculty of Agriculture at the University of Novi Sad, where he enrolled in the integrated Veterinary Medicine program. Graduating with an impressive GPA of 9.58, his undergraduate thesis explored blood plasma proteins in poultry, showcasing an early interest in biochemistry and physiological processes, both of which intersect with the study of Antibiotics. His passion for veterinary pharmacology and parasitology only deepened as he advanced to doctoral studies. From 2017 to 2023, Dr. Štrbac conducted rigorous research on the anthelmintic efficacy of essential oils, a project intricately linked with the search for plant-based alternatives to conventional Antibiotics. His PhD thesis was not only a scientific contribution to parasitology but also a forward-looking effort to reduce reliance on synthetic Antibiotics in animal health. This pivotal work set the stage for his future investigations into Antibiotics resistance, phytotherapy, and sustainable veterinary interventions—issues central to both public and animal health in the 21st century.

RESEARCH PASSIONS IN VETERINARY SCIENCE 🔬

Dr. Filip Štrbac’s research career is anchored in a multidisciplinary exploration of parasitology, veterinary pharmacology, and phytotherapy—fields deeply connected with the current global discourse on Antibiotics. At the University of Novi Sad and later at the Institute for Multidisciplinary Research in Belgrade, his projects consistently addressed the challenge of Antibiotics resistance by exploring alternatives from nature, particularly essential oils with anthelmintic properties. His groundbreaking in vitro and in vivo studies on gastrointestinal nematodes in sheep examined the pharmacodynamics of plant-based compounds, providing comparative data with traditional Antibiotics. These investigations not only validated the efficacy of natural compounds but also contributed to understanding the mechanisms by which certain pathogens develop resistance to conventional Antibiotics. His collaborative work across European institutions, including research stays in Italy and Spain, enabled a cross-cultural scientific exchange on sustainable veterinary practices. Moreover, his leadership roles in international COST Actions, such as COMBAR and MedPlants4Vet, allowed him to advance studies on minimizing the ecological impact of synthetic Antibiotics. As a result, Dr. Štrbac’s work straddles the boundaries of pharmacology and ecology, advancing veterinary science while actively promoting a global reduction in the use of Antibiotics, thereby contributing to the worldwide effort to curb antimicrobial resistance.

CONTRIBUTIONS TO ANIMAL HEALTH AND THERAPEUTICS 🐑

One of Dr. Filip Štrbac’s most significant contributions lies in his innovative approaches to animal health care, specifically through the development of phytopharmacological strategies that reduce dependence on synthetic Antibiotics. His detailed work on essential oils such as peppermint, oregano, and winter savory demonstrated measurable anthelmintic effects against sheep gastrointestinal nematodes, offering a functional and ecologically safer alternative to traditional Antibiotics. With over ten influential publications in peer-reviewed journals, including Frontiers in Veterinary Science and BMC Veterinary Research, Dr. Štrbac has shaped the veterinary landscape toward sustainable therapeutics. These studies provided compelling evidence of how plant-derived compounds can serve as frontline agents against parasitic infections, particularly in livestock—a sector often overburdened with Antibiotics usage. His interdisciplinary methodology, combining in vitro assays, field trials, and pharmacological modeling, reflects a commitment to scientific rigor and real-world application. Furthermore, his active role in environmental projects such as ENVIRANT underscores his dedication to understanding how Antibiotics affect both treated animals and surrounding ecosystems. Dr. Štrbac’s holistic view of veterinary pharmacology—bridging animal welfare, environmental health, and microbial resistance—positions him as a leader in redefining therapeutic practices beyond conventional Antibiotics-based protocols in veterinary medicine.

GLOBAL COLLABORATIONS AND SCIENTIFIC NETWORKS 🌍

Dr. Filip Štrbac has strategically positioned himself within the global scientific community through active collaboration and leadership in numerous European research networks, focusing on sustainable solutions to challenges posed by overuse of Antibiotics. His work in the COST Actions—such as COMBAR, MedPlants4Vet, ENVIRANT, and BeSafeBeeHoney—has addressed the pressing issue of Antibiotics resistance in livestock systems. By engaging in these consortia, Dr. Štrbac contributed to developing regulatory frameworks and scientific roadmaps for integrating phytotherapeutic alternatives to conventional Antibiotics. His research stays in Spain and Italy, particularly at the University of Naples Federico II and the CREMOPAR Center, were instrumental in aligning Serbian veterinary research with broader EU standards. These exchanges enabled him to co-develop diagnostic protocols and efficacy tests for plant-based treatments in parasitic infections, targeting pathogens commonly treated with Antibiotics. Through these partnerships, he has been a vocal advocate for integrating traditional herbal knowledge with modern veterinary science, a philosophy increasingly seen as vital for reducing overreliance on Antibiotics globally. As an expert evaluator for COST project proposals and a reviewer for high-impact journals in pharmacology and veterinary medicine, he continues to influence how the international community approaches responsible Antibiotics usage, reinforcing a shift toward sustainable, evidence-based parasitic disease control.

SCHOLARSHIP, PUBLICATIONS, AND RECOGNITION 🏅

Dr. Filip Štrbac’s scholarly output reflects both depth and innovation, especially in the context of exploring non-conventional therapies as viable complements or substitutes for Antibiotics. With more than ten peer-reviewed publications focused on essential oils and their pharmacological efficacy, he has emerged as a recognized figure in phytotherapy and veterinary parasitology. His articles often appear in high-impact journals such as Frontiers in Veterinary Science, Veterinary Sciences, and Pakistan Veterinary Journal, where he compares plant-based anthelmintics to standard Antibiotics. The scope of his work includes ovicidal, larvicidal, and adulticidal activities of bioactive compounds, bringing new insights into sustainable parasite control. His excellence has been acknowledged through numerous academic honors, including the Best Student of Generation award and national PhD scholarships funded by the Serbian Ministry of Education. These accolades underscore his scholarly commitment and reflect his aim to address Antibiotics resistance in both national and international contexts. Moreover, his role as a reviewer for leading scientific journals and as an expert evaluator for COST proposals further solidifies his status as a thought leader on alternatives to Antibiotics. Each recognition he has received is a testament to his mission: to challenge traditional paradigms and advance veterinary therapeutics beyond the limits of Antibiotics.

IMPACT ON FUTURE VETERINARY PRACTICE 🚀

Dr. Filip Štrbac’s innovative work has set the foundation for a future in veterinary medicine where sustainability and precision replace dependency on conventional Antibiotics. His research not only expands the therapeutic arsenal with botanically derived anthelmintics but also introduces new frameworks for understanding the ecological implications of prolonged Antibiotics usage. His in vivo trials using essential oils such as oregano and peppermint highlight how natural compounds can achieve comparable or even superior efficacy to traditional Antibiotics without promoting microbial resistance. This groundbreaking evidence supports a paradigm shift in how veterinarians, farmers, and pharmaceutical developers approach parasite management. Through his involvement in multi-national EU projects like eco2adapt and INTACT, Dr. Štrbac promotes the integration of ecosystem-based adaptation into veterinary care, with a special emphasis on minimizing Antibiotics spillover into the environment. His work directly contributes to the One Health movement, bridging human, animal, and environmental health through the reduction of Antibiotics overuse. Future veterinary practitioners, researchers, and policy-makers stand to benefit immensely from the models, data, and strategies he is pioneering. In redefining therapeutic protocols through science-backed phytotherapy, Dr. Štrbac is reshaping the trajectory of global veterinary medicine away from over-reliance on Antibiotics and toward a resilient, sustainable future.

LEGACY AND VISION FOR ANTIBIOTICS ALTERNATIVES 🌿

Dr. Filip Štrbac’s legacy is already being etched into the evolving narrative of modern veterinary pharmacology, especially through his contributions to Antibiotics alternatives. By identifying and validating the therapeutic potential of essential oils and plant extracts, he champions a future where natural remedies complement or replace synthetic Antibiotics in combating parasitic diseases. His vision is deeply aligned with global initiatives targeting antimicrobial resistance, environmental sustainability, and holistic health. As the principal investigator in several international and national projects, Dr. Štrbac continuously advocates for bridging ethnopharmacological traditions with cutting-edge scientific validation. His comprehensive approach—spanning phytochemical analysis, in vivo trials, and regulatory integration—makes his work a blueprint for future Antibiotics research. Beyond his publications and laboratory contributions, his mentorship of young scientists and his engagement in science diplomacy position him as a transformative figure in veterinary medicine. His future goals include expanding phytotherapy databases, developing standardized protocols for plant-based treatments, and influencing policy for regulated, sustainable Antibiotics use. In essence, Dr. Štrbac’s enduring impact will be measured not only by the reduced reliance on Antibiotics but also by the healthier animals, ecosystems, and communities that benefit from his science-driven, nature-inspired approach to veterinary health.

NOTABLE PUBLICATION

  • Title: Anthelmintic resistance in gastrointestinal nematodes of sheep: Current situation and novel strategies
    Authors: Filip Štrbac, Dragica Stojanović
    Journal: Conference Paper – 2024, FeMeSPRumNS

 

  • Title: Physiological role, pharmacokinetics and pharmacodynamics of niacin in cows
    Authors: Kosta Petrović, Dragica Stojanović, Filip Štrbac, Talija Hristovska
    Journal: Conference Paper – 2024, FeMeSPRumNS

 

  • Title: Botanical Control of Parasites in Veterinary Medicine
    Authors: Filip Štrbac, Slobodan Krnjajić, Dragica Stojanović, Nikolina Novakov, Antonio Bosco, Nataša Simin, Radomir Ratajac, Slađan Stanković, Giuseppe Cringoli, Laura Rinaldi
    Journal: Book Chapter – One Health Triad, Vol. III, 2023

 

  • Title: In Vitro and In Vivo Anthelmintic Efficacy of Peppermint (Mentha x piperita L.) Essential Oil against Gastrointestinal Nematodes of Sheep
    Authors: Filip Štrbac, Slobodan Krnjajić, Dragica Stojanović, Radomir Ratajac, Nataša Simin, Dejan Orčić, Laura Rinaldi, Elena Ciccone, Maria Paola Maurelli, Giuseppe Cringoli et al.
    Journal: Frontiers in Veterinary Science – 2023-08-10

 

  • Title: A Potential Anthelmintic Phytopharmacological Source of Origanum vulgare (L.) Essential Oil against Gastrointestinal Nematodes of Sheep
    Authors: Filip Štrbac, Slobodan Krnjajić, Maria Paola Maurelli, Dragica Stojanović, Nataša Simin, Dejan Orčić, Radomir Ratajac, Kosta Petrović, Goran Knežević, Giuseppe Cringoli et al.
    Journal: Animals – 2022-12-22

Jinmin Ma – Hepatitis – Best Researcher Award

Published on by Infectious

Jinmin Ma - Hepatitis - Best Researcher Award

BGI HuoYan Engineering - China

AUTHOR PROFILE

GOOGLE SCHOLAR

EARLY ACADEMIC JOURNEY 🎓

Dr. Jinmin Ma’s academic path laid a strong foundation for his lifelong commitment to advancing global health, particularly in the realm of Hepatitis research. He pursued his education in molecular biomedicine at the University of Copenhagen, Denmark, where he began delving into virology, pathogen-host interactions, and immune responses. His fascination with Hepatitis viruses—especially Hepatitis B and Hepatitis C—grew from these early investigations. Inspired by the burden of Hepatitis on public health worldwide, he focused on the molecular underpinnings of Hepatitis virus survival and replication. During his academic years, he engaged in numerous Hepatitis-related lab projects and developed specialized skills in RNA biology, viral pathogenesis, and molecular virology—all essential for understanding Hepatitis mechanisms. These academic pursuits enabled him to contribute early to the development of molecular detection tools for Hepatitis diagnosis. Even as a student, his drive to confront Hepatitis stood out, foreshadowing a prolific career centered on infectious diseases and Hepatitis. His thesis research on viral genomics offered valuable insight into the mutational patterns and gene expression shifts in Hepatitis. Today, his academic journey remains the cornerstone of his deep-seated expertise in Hepatitis virology. With Hepatitis driving his academic curiosity, Dr. Ma was set on a path to revolutionize the landscape of Hepatitis research.

INNOVATING THROUGH LEADERSHIP 🧬

Dr. Jinmin Ma’s transition from academic scholar to scientific leader marks a remarkable chapter in Hepatitis research. At BGI’s Infectious Disease Department, and later at HuoYan Engineering as Chief Technology Officer, he spearheaded multidisciplinary programs focusing on Hepatitis diagnostics, surveillance, and therapeutic strategies. Under his direction, high-throughput sequencing techniques were optimized to detect and characterize Hepatitis viruses with unprecedented accuracy. His leadership enabled the development of mRNA vaccine platforms targeting Hepatitis B, contributing to global strategies aimed at Hepatitis eradication. His professional milestones include managing grants from the Shenzhen Science and Technology Commission and the China Ministry of Science and Technology—many of which targeted Hepatitis prevention and personalized treatment. Dr. Ma also ensured that Hepatitis remained a top priority in infectious disease conferences and institutional research agendas. His stewardship fostered a dynamic research environment, integrating Hepatitis genomics, proteomics, and transcriptomics. By creating real-time molecular response systems for emerging Hepatitis outbreaks, he elevated public health responses. Dr. Ma’s leadership ensures that Hepatitis remains at the heart of institutional strategy, driving both national and international collaborations focused on Hepatitis control. His vision empowers new generations of researchers to keep Hepatitis prevention and treatment at the forefront of biomedical innovation.

RESEARCH AND DISCOVERY FRONTIERS 🔬

Dr. Jinmin Ma’s research on Hepatitis has significantly advanced our understanding of viral pathogenesis and host responses. His work encompasses over 80 publications, many centered on Hepatitis B and Hepatitis C virus biology. He was among the first to characterize genotype switching in Hepatitis B as a potential risk factor for vertical transmission. His studies revealed critical mechanisms by which Hepatitis viruses evade host immunity, contributing to chronic infection and liver damage. Through metagenomic sequencing and mRNA-based diagnostics, Dr. Ma has enhanced early detection strategies for Hepatitis, particularly in resource-limited settings. One of his landmark publications demonstrated how Hepatitis B virus (HBV) mutations affect viral persistence, adding depth to HBV evolutionary studies. His research also delved into transcriptomic profiling of Hepatitis-infected individuals, uncovering host immune suppression pathways. This led to the identification of novel biomarkers for disease staging and treatment efficacy. Dr. Ma has actively explored Hepatitis co-infections with other pathogens such as HIV and tuberculosis, assessing their synergistic effects on disease severity. He champions personalized medicine approaches tailored to Hepatitis genotypes and patient immune profiles. As Hepatitis remains a pressing global issue, Dr. Ma’s innovations continue to shape the future of Hepatitis diagnostics, therapeutics, and vaccine development.

IMPACT IN INFECTIOUS DISEASES 🌍

Few researchers have made such a comprehensive impact in infectious diseases as Dr. Jinmin Ma, especially in the context of Hepatitis. His scientific influence spans diverse domains—from molecular virology to public health policy—all unified by a central goal: to control and eliminate Hepatitis. He has played a vital role in reshaping national guidelines on Hepatitis surveillance through his integration of metatranscriptomic technologies. During the COVID-19 pandemic, he contributed to pandemic preparedness by applying Hepatitis research frameworks to RNA virus containment strategies. His tools for Hepatitis detection have been adapted for broader infectious disease surveillance, exemplifying cross-application of technologies. By working with multidisciplinary teams across genomics, immunology, and epidemiology, Dr. Ma has built comprehensive systems for Hepatitis outbreak response. He often emphasizes the interconnectedness of Hepatitis with social and economic determinants, advocating for equitable access to Hepatitis screening and treatment. His research has led to the implementation of molecular panels that detect multiple pathogens—including Hepatitis viruses—in a single assay. Through these efforts, he’s helped reduce the burden of Hepatitis-related liver disease in several regions. Dr. Ma’s holistic approach ensures that Hepatitis remains not only a research priority but also a cornerstone of modern infectious disease control strategies.

ACHIEVEMENTS AND ACCOLADES 🏅

Dr. Jinmin Ma’s contributions to Hepatitis research have earned him widespread recognition. He was honored as a Reserve Talent of High-Level Professional in Shenzhen, a testament to his pioneering work in Hepatitis virus surveillance and vaccine innovation. Numerous grants from the Shenzhen Science and Technology Commission and China’s Ministry of Science and Technology supported his Hepatitis-related breakthroughs. His publication record, boasting over 13,000 citations and an H-index of 14, highlights the global resonance of his Hepatitis-focused studies. As a reviewer for esteemed journals like The Lancet Respiratory Medicine and EClinicalMedicine, he evaluates cutting-edge research, often emphasizing Hepatitis virology. Dr. Ma’s editorial leadership for Frontiers in Cellular and Infection Microbiology has shaped special issues that highlight Hepatitis and co-infection dynamics. His accolades reflect a career devoted to translating Hepatitis science into life-saving technologies. He has also patented Hepatitis-related diagnostic systems, including methods for metagenomic classification and host immune profiling. These accolades not only honor individual achievement but also highlight the broader significance of Hepatitis research in the 21st century. As recognition of his work grows, so does the potential for Hepatitis control on a global scale. Through awards and impact, Dr. Ma keeps the fight against Hepatitis in sharp scientific and societal focus.

GLOBAL COLLABORATIONS AND KNOWLEDGE SHARING 🤝

Dr. Jinmin Ma’s Hepatitis research transcends borders, fostering a global network of scientific exchange. His collaborative projects with institutions in Europe, Southeast Asia, and Africa center around molecular epidemiology of Hepatitis viruses. These partnerships aim to standardize Hepatitis surveillance, especially in regions with high prevalence and limited diagnostic capacity. By organizing and contributing to international workshops, Dr. Ma disseminates the latest innovations in Hepatitis sequencing, resistance tracking, and vaccine design. His work with the University of Copenhagen and global virology consortia facilitates comparative analysis of Hepatitis strains across populations. He has also trained numerous junior researchers in techniques crucial to Hepatitis monitoring, such as mRNA quantification, droplet digital PCR, and metagenomics. This knowledge transfer accelerates Hepatitis eradication goals in resource-challenged areas. Dr. Ma ensures that Hepatitis research remains inclusive and collaborative, uniting virologists, clinicians, and data scientists under a shared mission. His joint publications on Hepatitis genotype shifts, co-infection with tuberculosis, and antiviral responses emphasize shared responsibility in public health. These efforts exemplify his belief that Hepatitis is a global issue requiring united scientific effort. Through cross-border collaboration, Dr. Ma elevates the standard and reach of Hepatitis research, ensuring knowledge translates into action worldwide.

LEGACY IN MOLECULAR VIROLOGY 🧪

Dr. Jinmin Ma’s legacy is firmly etched in the field of molecular virology, with Hepatitis at its center. He redefined approaches to studying Hepatitis virus structure, replication, and immune interaction by integrating bioinformatics and next-generation sequencing. His insights into Hepatitis B virus genome dynamics, including genotype switching and intra-host variability, are widely cited and referenced. His research showed how specific mutations in the Hepatitis B X gene could influence vertical transmission risks, a revelation that reshaped pediatric hepatology. Dr. Ma developed multi-pathogen diagnostic platforms that include sensitive detection for Hepatitis strains, making viral diagnostics more comprehensive. He also contributed to the early adoption of mRNA vaccine platforms tailored to Hepatitis control, influencing current vaccine strategies. His advocacy for real-time Hepatitis data analytics has improved outbreak forecasting models. Beyond bench science, his mentorship of early-career scientists has cultivated a new generation of Hepatitis researchers. Many of his trainees now lead their own Hepatitis-focused labs. Dr. Ma’s legacy isn’t confined to publications or patents—it lives in institutional frameworks and global dialogues on Hepatitis control. Through decades of persistent innovation, his molecular virology legacy cements Hepatitis as both a scientific challenge and a public health priority.

FUTURE VISIONS FOR HEPATITIS CONTROL 🚀

Looking ahead, Dr. Jinmin Ma envisions a world where Hepatitis is no longer a global health threat. He continues to push scientific boundaries by advancing ultra-rapid diagnostic tools that can detect emerging Hepatitis variants within hours. His current research explores personalized Hepatitis vaccines using real-time transcriptomic data to tailor immune responses. He is also piloting artificial intelligence models that predict Hepatitis treatment outcomes based on genetic and epigenetic signatures. These next-gen tools could revolutionize how we manage Hepatitis in both endemic and non-endemic regions. Dr. Ma advocates for stronger integration of Hepatitis diagnostics into routine healthcare systems, especially in underserved areas. He’s also proposing cloud-based surveillance platforms to share Hepatitis data across national borders in real time. As climate change alters viral transmission patterns, Dr. Ma is studying how environmental shifts impact Hepatitis epidemiology. Through strategic collaborations, he hopes to bring affordable and scalable Hepatitis interventions to communities worldwide. His future plans include establishing a dedicated Hepatitis Innovation Hub within BGI to consolidate research, training, and implementation efforts. Dr. Ma’s forward-looking approach ensures that Hepatitis remains a solvable challenge through science, collaboration, and dedication. His vision inspires a new era in Hepatitis prevention, treatment, and global elimination efforts.

NOTABLE PUBLICATION

  • Title: Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
    Authors: R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, W. Wang, H. Song, B. Huang, ...
    Journal: The Lancet, Vol. 395 (10224), pages 565–574, 2020

  • Title: Selection of reference genes for quantitative real-time PCR in bamboo (Phyllostachys edulis)
    Authors: C. Fan, J. Ma, Q. Guo, X. Li, H. Wang, M. Lu
    Journal: PLOS ONE, Vol. 8 (2), e56573, 2013

  • Title: Dominant subtype switch in avian influenza viruses during 2016–2019 in China
    Authors: Y. Bi, J. Li, S. Li, G. Fu, T. Jin, C. Zhang, Y. Yang, Z. Ma, W. Tian, J. Li, S. Xiao, ...
    Journal: Nature Communications, Vol. 11 (1), Article 5909, 2020

  • Title: Altered respiratory virome and serum cytokine profile associated with recurrent respiratory tract infections in children
    Authors: Y. Li, X. Fu, J. Ma, J. Zhang, Y. Hu, W. Dong, Z. Wan, Q. Li, Y.Q. Kuang, K. Lan, ...
    Journal: Nature Communications, Vol. 10 (1), Article 2288, 2019

  • Title: Sequence recombination and conservation of Varroa destructor virus-1 and deformed wing virus in field collected honey bees (Apis mellifera)
    Authors: H. Wang, J. Xie, T.G. Shreeve, J. Ma, D.W. Pallett, L.A. King, R.D. Possee
    Journal: PLOS ONE, Vol. 8 (9), e74508, 2013

Dayu Liu – Diagnosis of Infectious Diseases – Best Researcher Award

Published on by Infectious

Dayu Liu - Diagnosis of Infectious Diseases - Best Researcher Award

the Second Affiliated Hospital, School of Medicine, South China University of Technology - China

AUTHOR PROFILE

SCOPUS

EARLY ROOTS IN MEDICAL SCIENCE 🧬

Dr. Dayu Liu's foundational journey into the world of science began with a Bachelor of Science in Clinical Medicine from Dalian Medical University, where he cultivated a strong interest in pathology and diagnostics. He further refined his expertise through a Master’s in Pathology at the same university, driven by his passion for biomedical research. Motivated to explore the frontiers of analytical innovation, Dr. Liu pursued a Ph.D. in Analytical Chemistry at the University of Chinese Academy of Sciences (UCAS), where his thesis focused on microfluidic chip research. This advanced study marked the inception of his specialization in micro-analytical systems, a field directly contributing to the advancement of the Diagnosis of Infectious Diseases. Through these early academic pursuits, Dr. Liu not only gained technical mastery but also a comprehensive understanding of how microfluidic systems could be applied to rapidly detect and monitor pathogens. These experiences laid the scientific and clinical groundwork that now defines his work. Today, his early education continues to inform his cutting-edge innovations in laboratory medicine, exemplifying how fundamental medical training can evolve into pioneering research impacting the Diagnosis of Infectious Diseases globally.

MICROFLUIDIC BREAKTHROUGHS IN DIAGNOSTICS 🔬

Dr. Liu’s groundbreaking work in microfluidic chip technology stands at the intersection of engineering and medicine, revolutionizing the Diagnosis of Infectious Diseases. As Director of the Microfluidic In Vitro Diagnostics Laboratory at the Second Affiliated Hospital of South China University of Technology, he leads transformative research in developing portable, rapid, and precise diagnostic platforms. His postdoctoral tenure at the Hong Kong University of Science and Technology provided him with essential experience in micro-analytical systems, which he has since applied to real-world healthcare challenges. By engineering chips capable of analyzing minute biological samples, Dr. Liu has enabled quicker and more cost-effective diagnostics, especially vital for early-stage detection of infectious diseases. His work in this domain includes the creation of high-content diagnostic systems that can process large volumes of patient data, thereby improving the accuracy and speed of infectious disease detection. These advancements are essential for responding to disease outbreaks and managing global health emergencies. His technology also supports personalized medicine, ensuring that patients receive treatments tailored to their biological profiles. Through microfluidics, Dr. Liu is not only enhancing laboratory workflows but also redefining the operational standards for the Diagnosis of Infectious Diseases in both clinical and remote settings.

PIONEERING RESEARCH AND GLOBAL IMPACT 🌍

Dr. Dayu Liu has emerged as a leading voice in the global scientific community through his contributions to diagnostic research. His work has significant implications for public health, particularly in the Diagnosis of Infectious Diseases, where accurate and timely detection can mean the difference between containment and catastrophe. As a principal investigator for five National Natural Science Foundation of China (NSFC) General Program Grants and over ten provincial and municipal research projects, Dr. Liu has secured consistent support for his groundbreaking research. His studies bridge the gap between laboratory innovation and clinical application, especially in under-resourced healthcare systems. His focus on developing microfluidic chip-based diagnostics has enabled large-scale screening and epidemiological surveillance, bolstering global preparedness for infectious disease threats. Through collaborations with international journals and institutions, he disseminates knowledge that transcends borders. His scholarly contributions, with over 50 peer-reviewed articles, have introduced novel methodologies now employed by diagnostics labs around the world. In championing scientific transparency and reproducibility, Dr. Liu's research continues to inform policy and practice related to the Diagnosis of Infectious Diseases, illustrating the role of academic innovation in safeguarding human health on a global scale.

TECHNOLOGICAL INNOVATION IN LABORATORY MEDICINE ⚙️

Technological ingenuity is at the heart of Dr. Liu's contributions to laboratory medicine, particularly concerning the Diagnosis of Infectious Diseases. By designing and engineering microfluidic platforms, he has pushed the boundaries of what’s possible in diagnostic technology. His innovations offer compact, easy-to-use, and highly accurate tools that are reshaping how infectious agents are identified and quantified. As a researcher at the Second Affiliated Hospital of South China University of Technology, he continually translates engineering principles into medical breakthroughs. His laboratory focuses on producing integrated systems capable of simultaneously analyzing multiple biomarkers—crucial for differentiating between viral and bacterial infections quickly. With more than 20 patents to his name, Dr. Liu's inventions extend beyond academia, providing commercial and clinical avenues for next-generation diagnostics. These systems have already shown effectiveness in detecting diseases like COVID-19, dengue, and tuberculosis, aligning with global efforts to strengthen disease surveillance. Through innovation in biosensors, signal amplification, and sample handling, his lab sets new standards in point-of-care diagnostics. As infectious diseases remain a persistent threat, Dr. Liu’s technology ensures that the Diagnosis of Infectious Diseases becomes more responsive, affordable, and accessible, fulfilling urgent global health needs.

MENTORSHIP AND ACADEMIC LEADERSHIP 🎓

Beyond the laboratory bench, Dr. Liu plays a vital role in shaping future scientific leaders. As an advisor for both Master's and Ph.D. students at South China University of Technology, he actively mentors the next generation of researchers, many of whom are now working on projects directly related to the Diagnosis of Infectious Diseases. His mentorship philosophy emphasizes rigorous methodology, interdisciplinary collaboration, and ethical responsibility. Under his guidance, students are trained in advanced diagnostic technologies, including microfluidics, bioinformatics, and molecular biology. Dr. Liu encourages his mentees to bridge research and real-world application, ensuring their work remains clinically relevant. He has cultivated a thriving academic environment where curiosity and innovation are prioritized. His influence as a mentor extends through co-authored publications, joint patent applications, and international conference presentations. Many of his students have gone on to secure academic and industry positions, contributing to global efforts in disease detection and management. Dr. Liu’s dedication to education not only amplifies his impact but also ensures that the field of Diagnosis of Infectious Diseases continues to evolve, benefiting from the fresh perspectives and skills of well-trained young scientists.

SCIENTIFIC ACHIEVEMENTS AND RECOGNITION 🏅

Dr. Dayu Liu’s prolific scientific output and numerous accolades reflect his standing in the international research community. With over 50 peer-reviewed articles in renowned journals such as Advanced Science, Lab on a Chip, and Analytical Chemistry, his work has consistently advanced the field of Diagnosis of Infectious Diseases. His research is widely cited and has influenced diagnostic protocols and policy formulations. Dr. Liu’s intellectual property portfolio includes more than 20 patents, many of which have practical applications in commercial diagnostic kits. These contributions have earned him regional and national recognition, solidifying his reputation as a leading innovator in diagnostic medicine. He is frequently invited to speak at global conferences and serve on editorial boards, further underscoring the international value of his research. Awards from scientific societies and funding bodies have validated the impact of his work on both clinical practice and public health. Dr. Liu’s achievements illustrate a career committed to solving real-world problems through scientific inquiry. His advancements continue to inspire other researchers and contribute to a more precise, rapid, and scalable approach to the Diagnosis of Infectious Diseases, thereby enhancing disease control and patient care globally.

VISION FOR THE FUTURE OF DIAGNOSTICS 🔮

Looking forward, Dr. Liu envisions a diagnostic landscape where rapid, decentralized, and personalized testing becomes the norm, especially in the realm of the Diagnosis of Infectious Diseases. His future work aims to integrate artificial intelligence and machine learning into microfluidic systems to enable predictive diagnostics. By harnessing big data and cloud-based platforms, he aspires to create real-time monitoring tools that can anticipate outbreaks before they spread. His lab is currently exploring novel biosensors capable of detecting emerging pathogens with unprecedented sensitivity. Dr. Liu also plans to expand collaborations with international institutions to promote technology transfer and equitable access to diagnostics in low-resource settings. His commitment to sustainable and scalable solutions will be critical in tackling future pandemics and antimicrobial resistance. Through continuous innovation and interdisciplinary synergy, Dr. Liu is determined to make diagnostics more inclusive, accurate, and efficient. As he charts the path forward, his work remains grounded in one central mission: advancing the Diagnosis of Infectious Diseases to protect global health. His legacy will not only be measured in patents or publications but in lives saved and healthcare systems strengthened through intelligent, accessible diagnostic science.

NOTABLE PUBLICATION

  • Title: Pheno-Molecular Testing Enabled by Multiplex Droplet Digital PCR for Rapid and High-Content Detection of Carbapenem-Resistant Enterobacterales
    Journal: Analytical Chemistry
    Authors: (Author names not specified in the input — please provide or clarify if needed)

  • Title: Droplet Pairing-Merging Enabled Digital RPA-CRISPR/Cas12a (DIMERIC) Assay for Rapid and Precise Quantification of Hepatitis B Virus DNA
    Journal: Biosensors and Bioelectronics
    Authors: (Author names not specified in the input)

  • Title: Automated Droplet Ejection from a Digital Microfluidics Sample Pretreatment Device Enables Batch-Mode Chemiluminescence Immunoassay
    Journal: Analytical Chemistry
    Authors: (Author names not specified in the input)

  • Title: Forming Single-Cell-Derived Colon Cancer Organoid Arrays on a Microfluidic Chip for High Throughput Tumor Heterogeneity Analysis
    Journal: ACS Biomaterials Science and Engineering
    Authors: (Author names not specified in the input)

  • Title: Selective Expansion of Renal Cancer Stem Cells Using Microfluidic Single-Cell Culture Arrays for Anticancer Drug Testing
    Journal: Lab on a Chip
    Authors: (Author names not specified in the input)

Theodora Mahoukede Zohoncon – Hepatitis – Best Researcher Award

Published on by Infectious

Theodora Mahoukede Zohoncon - Hepatitis - Best Researcher Award

Université Saint Thomas d'Aquin - Burkina Faso

AUTHOR PROFILE

ORCID

ACADEMIC ROOTS AND RISING 🌱

Prof. ZOHONCON Theodora M.’s academic journey began with a robust foundation in pharmacy, laying the groundwork for a future in scientific leadership. She earned her Doctorate in Pharmacy (PharmD) and later specialized in medical biology with a strong research orientation. Her early educational achievements were not merely academic milestones but stepping stones into deeper biomedical inquiries, particularly infectious diseases such as Hepatitis. This early exposure inspired her to pursue advanced research degrees, culminating in a PhD in Applied Microbiology and Immunology. Her initial focus on microbial pathogenesis and clinical diagnostics paved the way for her career-long engagement with virology. With a growing interest in Hepatitis research, she developed laboratory skills and theoretical insight that would eventually translate into impactful public health applications. Her academic rigor was matched by a passion for mentorship, demonstrated by her commitment to training students and supervising theses in related biomedical disciplines. Her foundational years reveal a scholar devoted to science and service, where Hepatitis studies began to form the nucleus of a broader agenda addressing viral infections in Africa. From her earliest lectures to her laboratory milestones, Prof. ZOHONCON’s academic roots illustrate a steady ascent anchored in excellence, with Hepatitis always central to her evolving research identity.

PROFESSIONAL MILESTONES & LEADERSHIP 🏛️

Prof. ZOHONCON has risen to become a key figure in biomedical sciences and health administration. As a university professor and director of multiple laboratories, she has consistently blended academic insight with institutional leadership. Her tenure at Joseph Ki-Zerbo University is marked by dedicated teaching and pivotal administrative roles, including positions on ethics committees and curriculum development boards. A significant portion of her professional path has been devoted to the development of diagnostic protocols for viral diseases, particularly Hepatitis. She has overseen critical infrastructure that supports molecular biology, immunology, and microbiological research while also leading public health-focused initiatives. Her work with national and regional networks further exemplifies her commitment to applied science that benefits community health. As a respected voice in virological surveillance and biosafety, Prof. ZOHONCON regularly collaborates with health ministries and international bodies to combat Hepatitis outbreaks. These collaborations bridge the gap between academic research and real-world medical needs. Her leadership positions are not only testaments to her administrative capacity but reflect her advocacy for prioritizing Hepatitis control and research in national health strategies. In every professional milestone, her emphasis on Hepatitis as a public health priority has remained constant and resolute.

SCIENTIFIC CONTRIBUTIONS IN HEPATITIS RESEARCH 🔬

Prof. ZOHONCON’s scientific portfolio is rich with impactful research in virology, with a particular emphasis on Hepatitis viruses. Her contributions span the development of diagnostic tools, laboratory biosafety protocols, and epidemiological surveillance techniques. One of her most significant scientific endeavors includes studies on the molecular epidemiology of Hepatitis B and C, helping to elucidate transmission pathways and genotypic variations in Burkina Faso and the West African region. Through her publications and collaborative projects, she has contributed to a better understanding of viral hepatitis prevalence, risk factors, and resistance patterns. She played a leading role in projects funded by international organizations focused on improving the early detection and treatment outcomes of Hepatitis infections. Her research is guided by a vision to make diagnostics accessible and reliable in low-resource settings. Beyond lab-based work, she’s involved in translating research into health policy, aiming to improve national response strategies against Hepatitis. Her ability to navigate both the academic and applied realms has positioned her as a regional authority on Hepatitis virology. Through dozens of scientific articles, conference presentations, and field surveys, Prof. ZOHONCON has continually advanced the frontiers of knowledge in Hepatitis research, directly influencing public health protocols and disease control efforts.

GLOBAL COLLABORATIONS AND NETWORKS 🌍

International collaboration has been a cornerstone of Prof. ZOHONCON’s strategy in elevating Hepatitis research. Her partnerships with institutions across Africa, Europe, and international health agencies have catalyzed critical research into viral epidemiology and immunopathology. She has participated in WHO-sponsored programs and has led collaborative studies with institutions such as the Institut Pasteur and the West African Health Organization (WAHO), focusing on capacity building and laboratory diagnostics for Hepatitis and other viral infections. These global engagements not only advanced her own research but also enhanced regional preparedness through training programs, inter-laboratory benchmarking, and the development of diagnostic guidelines. Prof. ZOHONCON has emphasized the need for a cross-border approach to tackle Hepatitis, considering the migratory nature of populations and the variable access to healthcare infrastructure. Her ability to synthesize international standards with local realities has made her a valuable liaison between Burkina Faso’s health system and global research agendas. These alliances have yielded joint publications, regional policy briefs, and enhanced research funding channels. By fostering an international research ecosystem, Prof. ZOHONCON ensures that Hepatitis remains on the global health agenda, with African data and perspectives significantly shaping future directions.

TEACHING AND MENTORSHIP LEGACY 👩‍🏫

Prof. ZOHONCON is deeply invested in the academic and professional development of future scientists. Her lectures in immunology, virology, and molecular diagnostics have shaped hundreds of students, many of whom now contribute to the medical sciences and public health. As a supervisor and mentor for undergraduate, master's, and doctoral candidates, she has consistently emphasized the importance of research in diseases like Hepatitis. Her mentorship goes beyond technical knowledge—she instills in her mentees a sense of responsibility toward addressing the health challenges of the region. Several of her supervised theses and student projects have directly contributed to understanding Hepatitis epidemiology, prevention, and diagnosis. She also organizes hands-on laboratory training and workshops, often in collaboration with regional networks, to ensure that students gain both theoretical and practical competencies. Prof. ZOHONCON's teaching philosophy integrates research with application, particularly in the context of Hepatitis, ensuring that learners understand both the science and the social impact of their work. Her mentorship legacy is reflected in a growing community of African researchers and healthcare professionals equipped to confront viral infections, with Hepatitis remaining a central theme in their academic journeys and professional endeavors.

AWARDS, HONORS, AND RECOGNITION 🏅

Prof. ZOHONCON’s distinguished contributions have earned her numerous accolades, solidifying her as a prominent voice in biomedical sciences. Recognized both nationally and internationally, she has received awards for excellence in teaching, groundbreaking research, and public health leadership. Her work on Hepatitis diagnostics and epidemiology has been particularly praised, receiving commendations from academic societies and health agencies alike. One of her most prestigious honors includes recognition from the Ministry of Health for her advisory role in Hepatitis control programs and her impact on laboratory capacity strengthening. She has been invited as a keynote speaker at major virology and infectious disease conferences, where her insights on Hepatitis surveillance and public health policies are highly sought. These recognitions are not only personal achievements but also reinforce the visibility and urgency of Hepatitis research in global and regional scientific discourse. Through every award, Prof. ZOHONCON reaffirms her dedication to leveraging science for societal benefit. Her accolades reflect a career not just of excellence, but of enduring impact—especially in the fight against Hepatitis and its associated health burdens.

FUTURE VISION AND LASTING IMPACT 🌟

Looking ahead, Prof. ZOHONCON envisions a future where Hepatitis is no longer a silent epidemic in Africa. Her ongoing projects focus on strengthening early detection frameworks, expanding molecular diagnostic capabilities, and promoting vaccination coverage—especially in underserved communities. She is actively pursuing research that intersects genomics and public health to better predict Hepatitis outbreaks and resistance patterns. Her long-term goal is to establish a center of excellence in West Africa dedicated to virology and infectious diseases, with Hepatitis research as a flagship focus. Beyond scientific aims, she advocates for policy reform and education campaigns to demystify Hepatitis and reduce stigma. Her impact will continue through her mentees, institutional initiatives, and international collaborations. Prof. ZOHONCON’s legacy is rooted in her unwavering dedication to science as a tool for transformation. As she continues to lead from the lab, the lecture hall, and the policy table, she exemplifies how a singular focus—such as Hepatitis—can become the nucleus of widespread change. Her future contributions promise to leave an indelible mark on both the scientific community and the public health landscape of Africa and beyond.

NOTABLE PUBLICATION

  • Title: Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso
    Authors: Adico MDW, Zouré AA, Sombié HK, Kiendrebeogo TI, Dabré S, Amegnona LJ, Bakyono BS, Traoré L, Ouedraogo TC, Ouedraogo RA, et al.
    Journal: Molecular Genetics & Genomic Medicine
  • Title: Carriage of Ser217Leu and Ala541Thr Variants of ELAC2 Gene and Risk Factors in Patients with Prostate Cancer in Burkina Faso
    Authors: Traoré ADD, Ky BD, Traoré L, Zohoncon TM, Zouré AA, Yonli AT, Sombié HK, Sorgho PA, Elvira Bazié BVJT, Tovo SFA, et al.
    Journal: Prostate Cancer
  • Title: KIR2DL2, KIR2DL5A and KIR2DL5B Genes Induce Susceptibility to Dengue Virus Infection, while KIR3DL3 and KIR2DS5 Confer Protection
    Authors: Tapsoba ASA, Djigma FW, Bayala B, Sorgho PA, Traore L, Zohoncon TM, Bello SOT, Bado P, Bazie BVEJT, Yougbare F, et al.
    Journal: Mediterranean Journal of Hematology and Infectious Diseases
  • Title: First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou/Burkina Faso
    Authors: Dovo EE, Zohoncon TM, Tovo SF, Soubeiga ST, Kiendrebeogo IT, Yonli AT, Ouedraogo RA, Dabire AM, Djigma FW, Nadembega CW, et al.
    Journal: BMC Infectious Diseases
  • Title: Molecular Epidemiology of Human Herpes Virus Type 8 Among Patients with Compromised Immune System in Ouagadougou, Burkina Faso
    Authors: Biatougou NM, Ouedraogo MS, Soubeiga ST, Zohoncon TM, Ouedraogo P, Obiri-Yeboah D, Tapsoba ASA, Kiendrebeogo TI, Sagna T, Niamba P, et al.
    Journal: HIV/AIDS (Auckland, N.Z.)

Anara Babayeva – Antibiotics – Best Researcher Award

Published on by Infectious

Anara Babayeva - Antibiotics - Best Researcher Award

Mugla Sıtkı Kocman University - Turkey

AUTHOR PROFILE 

GOOGLE SCHOLAR

EARLY ACADEMIC ROOTS 🌱

Anara Babayeva, born in Baku, Azerbaijan, on February 9, 1993, embarked on her academic journey with a passion for biology that would soon shape a compelling scientific career. After completing high school at A.S. Xalilov No. 263, she earned her bachelor's degree in biology from Azerbaijan State Pedagogical University. Her academic curiosity led her to Turkey, where she pursued and completed her master’s degree in biology at Muğla Sıtkı Koçman University. It was during this period that Anara began cultivating her deep scientific interest in molecular biology, microbiology, and the emerging field of functional genomics. The foundation she built during these formative years prepared her to engage in highly complex studies involving transcriptomics, metabolomics, and proteomics—fields crucial in the global fight against resistant bacteria. Even as a student, she was drawn to innovative research areas, especially the use of natural compounds and novel molecules like boron-derived antibiotics. Her early education served as a launchpad for numerous national and international research projects focused on bacterial gene expression, antimicrobial resistance, and metabolic profiling. Her work consistently demonstrated both a profound understanding of biological systems and a visionary approach toward leveraging antibiotics for therapeutic and diagnostic breakthroughs.

ADVANCED SCIENTIFIC EXPLORATIONS 🔬

At the graduate and post-graduate levels, Anara Babayeva immersed herself in the intricacies of biotechnology and molecular research. Her focus sharpened on developing novel methodologies to understand how antibiotics, particularly boron-containing compounds like epetraborole, interact with pathogenic strains such as Escherichia coli. At Muğla Sıtkı Koçman University, she became an active researcher in various TÜBİTAK and BAP-funded projects, contributing significantly to studies investigating bacterial gene responses, antimicrobial resistance, and phenolic compounds. Anara's efforts included advanced proteomic and transcriptomic analyses, often utilizing nano LC-MS/MS, 2D gel electrophoresis, and microarray platforms. Her expertise expanded through work on functional genomics, including KEIO mutant screening and ASKA clone analysis, highlighting her unique ability to decode complex genetic systems. Through these cutting-edge methods, Anara explored the biochemical and genomic impact of antibiotics on cellular networks. This phase of her career showcased not just technical proficiency but also a bold drive to innovate in diagnostics and treatment methodologies. Her work during this period not only contributed to scientific literature but also provided a deeper understanding of how natural compounds and synthetic antibiotics could serve as the cornerstone of next-generation antimicrobial strategies.

GROUNDBREAKING RESEARCH IN ANTIBIOTICS 🧪

Anara Babayeva’s scientific pursuits have consistently centered around the dynamic and urgent field of antibiotics research. Her hallmark contributions involve the investigation of epetraborole, a boron-containing experimental drug, and its mechanisms against bacterial strains. She has taken a leading role in several TÜBİTAK-funded projects examining how specific genes and proteins in Escherichia coli respond to antimicrobial stress, using technologies like NMR metabolomics and proteomics to detect subtle molecular changes. In particular, her research revealed novel gene targets and metabolic pathways affected by boron-based antibiotics, advancing our understanding of bacterial resistance and tolerance mechanisms. Through transcriptomic profiling, she has mapped how gene overexpression or deletion can modify bacterial behavior under drug pressure. These insights are essential in combating multidrug-resistant organisms, which pose a growing threat to global health. Anara’s ability to synthesize bioinformatics data with wet-lab experimentation has propelled her work to the forefront of functional antibiotic discovery. Her pioneering studies underscore how interdisciplinary approaches can unlock powerful antimicrobial solutions, turning theoretical findings into practical applications. By bridging molecular biology and clinical microbiology, she continues to redefine how antibiotics are conceptualized and tested in modern laboratories.

NATURAL COMPOUNDS AND ANTIMICROBIAL INNOVATION 🌿

In addition to synthetic antibiotics, Anara Babayeva has conducted extensive research on natural compounds with antimicrobial properties. Her investigations into Turkish propolis, phenolic acids, and even sea urchin extracts highlight her interest in exploring bioactive molecules from diverse ecosystems. She played key roles in studies examining the antimicrobial and anticancer effects of substances like Dracunculus vulgaris, Rosularia serrata, Amanita virosa, and Trichaptum biforme. These experiments often employed metabolomic profiling and transcriptomic studies to determine how natural extracts affect microbial survival, with findings suggesting that nature-derived compounds could complement traditional antibiotics or even pave the way for new drug classes. By examining how compounds such as propolis influence nucleic acid metabolism and protein expression in E. coli, Anara has contributed important data to the field of natural product pharmacology. Her research also sheds light on how bacteria develop resistance or tolerance to both synthetic and natural antimicrobial agents. This dual approach—studying both commercial antibiotics and bioactive compounds—illustrates her comprehensive understanding of microbial defense strategies and her commitment to uncovering sustainable, multifaceted antimicrobial therapies.

ACCOLADES AND ACADEMIC CONTRIBUTIONS 🏆

Throughout her career, Anara Babayeva has earned widespread recognition for her contributions to molecular biology and antibiotics research. Her scholarly work has been featured in respected journals such as Frontiers in Life Sciences and Related Technologies, Journal of Applied Microbiology, and International Journal of Peptide Research and Therapeutics. She has authored and co-authored impactful studies on epetraborole, bacterial gene responses, and antimicrobial resistance. Moreover, Anara has presented her findings at prominent international conferences, where her work on boron-based antibiotics, gene expression, and metabolomics has drawn praise from the academic community. Her participation in events such as the International Proteomics Congress and multiple TÜBİTAK conferences demonstrates her active engagement in scientific dialogue. Her reputation as an innovative and meticulous researcher has made her a respected figure in the antibiotic discovery field. Notably, her efforts are not limited to publication—she has been actively involved in mentoring, conducting experimental designs, and guiding younger researchers in the lab. These contributions ensure that her knowledge and passion for antibiotics continue to influence future scientific exploration and public health advancements.

SCIENTIFIC IMPACT AND GLOBAL REACH 🌍

Anara Babayeva’s research has transcended national boundaries, contributing valuable insights to the global scientific community’s understanding of antibiotics. Her interdisciplinary methodology—integrating genomics, proteomics, and metabolomics—has made significant strides in elucidating how bacteria interact with both synthetic and natural antimicrobial agents. By targeting genes associated with resistance and metabolic adaptation, she has helped pinpoint vulnerable molecular pathways, offering promising new targets for therapeutic development. Anara’s findings not only contribute to scientific journals but also inform broader discussions on antibiotic stewardship and resistance management worldwide. Her work is increasingly relevant in the age of rising antibiotic-resistant infections, especially as health organizations emphasize the need for next-generation antimicrobial drugs. Collaborations with international partners and participation in bilateral research projects further highlight her influence beyond Turkey and Azerbaijan. Her data on propolis and boron-derived antibiotics have implications for pharmaceutical development, bioengineering, and public health strategies. Anara’s science-driven advocacy promotes rational drug design and emphasizes a balance between innovation and sustainability in the use of antibiotics, making her a crucial voice in the global effort to protect the efficacy of life-saving antimicrobial therapies.

VISION FOR THE FUTURE OF ANTIBIOTICS RESEARCH 🔭

Looking ahead, Anara Babayeva envisions a future where advanced technologies converge to develop smarter, safer, and more sustainable antibiotics. Her ongoing research focuses on identifying novel gene-drug interactions, using tools like CRISPR screening, AI-driven bioinformatics, and NMR-based metabolomics. With a strong foundation in functional genomics and microbial systems biology, she aims to build integrated models that predict bacterial responses to emerging drug candidates. She is particularly interested in the synergy between synthetic molecules and natural extracts, which could minimize resistance development while enhancing drug efficacy. Future projects include studying microbial ecology under antimicrobial stress and developing biosensors for antibiotic susceptibility testing. Anara is also committed to mentoring a new generation of scientists who can carry forward the fight against antibiotic resistance. As antibiotics become an increasingly precious resource, her research will help redefine how they are developed, prescribed, and preserved. Her legacy is poised to be one of scientific rigor and visionary leadership—pioneering not just new compounds but also a paradigm shift in how the world understands and utilizes antibiotics for both human and environmental health.

NOTABLE PUBLICATION

  • Title: NMR metabolomics analysis of Escherichia coli cells treated with Turkish propolis water extract reveals nucleic acid metabolism as the major target
    Authors: ES Elgin, ŞS Çatav, A Babayeva, H Kim, E Dibek, B Çöl, YK Chae, ...
    Journal: Journal of Applied Microbiology

 

  • Title: Bor içeren bazı biyoaktif bileşikler
    Authors: E Dibek, A Babayeva, MS Kürkçü, NA Çöl, B Çöl
    Journal: Journal of Boron

 

  • Title: Genome-wide screen of Escherichia coli Keio mutant line identifies genes related to propolis effect
    Authors: E Dibek, A Babayeva, ES Elgin, MS Kürkçü, B Çöl
    Journal: European Food Research and Technology

 

  • Title: The Cytotoxic Effects of Turkish Bee Venom (Apis mellifera) on Selected Cancer Cell Lines
    Authors: A Babayeva, E Dibek, İ Kıvrak, B Çöl
    Journal: International Journal of Peptide Research and Therapeutics

 

  • Title: Genome-wide Screening of the Escherichia coli Keio Knockout Collection Identifies Genetic Determinants of Epetraborole Hypersusceptibility
    Authors: A Babayeva, B Çöl
    Journal: European Journal of Clinical Microbiology & Infectious Diseases

Edmund Ossai – Tuberculosis – Best Researcher Award

Published on by Infectious

Edmund Ossai - Tuberculosis - Best Researcher Award

Ebonyi State University Abakaliki, Nigeria - Nigeria

AUTHOR PROFILE

GOOGLE SCHOLAR

EARLY ACADEMIC FOUNDATIONS 🎓 | TUBERCULOSIS PATHWAY BEGINS

Dr. Edmund Ndudi Ossai's journey into the realm of public health and Tuberculosis research began with a strong academic background rooted in medicine. His education at the College of Health Sciences, Ebonyi State University, Abakaliki, Nigeria, laid a foundational understanding of community medicine—an essential field in combating infectious diseases. Early in his career, he demonstrated a sharp interest in disease epidemiology, especially diseases with widespread public health impacts like Tuberculosis. These academic pursuits eventually led him to embrace research that integrates technology with community-based health strategies. Dr. Ossai’s capacity for interdisciplinary learning and his consistent focus on infectious diseases positioned him as a valuable contributor to Nigeria's health sector. Tuberculosis, with its deep societal and clinical implications, became a central concern in his research and professional outlook. His early exposure to the burden of TB in developing regions inspired him to investigate not just the biological aspects of the disease, but also the operational and systemic bottlenecks in diagnostic systems. This early academic period was marked by curiosity, innovation, and a desire to create sustainable public health solutions that would later shape his renowned work in Truenat-based TB diagnostics across Nigerian health facilities.

PROFESSIONAL ENDEAVORS ⚕️ | DRIVING TUBERCULOSIS DIAGNOSTICS

In his professional journey, Dr. Edmund Ndudi Ossai has emerged as a pivotal figure in Nigeria’s Tuberculosis control initiatives. As a faculty member in the Department of Community Medicine at Ebonyi State University, he has balanced academic roles with active field engagement. His most significant contribution came during his involvement with the pilot implementation of Truenat diagnostic platforms across 38 health facilities in Nigeria. Tuberculosis remains a leading health challenge in the country, and Dr. Ossai’s work targeted the systemic errors in existing diagnostic chains. The research he led focused on identifying factors responsible for unsuccessful tests and high error rates, revealing that while error rates were generally low, specific facility-level issues like cartridge errors and PCR internal control failures needed urgent intervention. Under his leadership, evidence-based strategies were proposed to enhance training curricula for laboratory personnel and improve operational efficiency. Through collaborative work with agencies like the Federal Ministry of Health, USAID, and the Stop TB Partnership, his professional trajectory has continuously intersected with global Tuberculosis eradication goals. Dr. Ossai’s career is a testament to applied public health work—where scientific inquiry is directly tied to the betterment of diagnostic infrastructure and TB patient outcomes.

RESEARCH FOCUS 🔬 | INNOVATIONS AGAINST TUBERCULOSIS

The cornerstone of Dr. Edmund Ndudi Ossai’s research lies in improving diagnostic efficiency for Tuberculosis in Nigeria. He spearheaded a groundbreaking retrospective cross-sectional study analyzing over 56,000 Truenat DNA extractions and MTB test results. This meticulous work provided actionable insights into the error rates of Truenat diagnostic platforms, which were relatively low—1.8% for Trueprep DNA extraction and 2.4% for Truenat MTB tests. His research did not stop at mere statistics; it delved into the root causes of high error rates such as cartridge malfunction and internal control failures in PCR procedures. Tuberculosis control heavily depends on accurate and timely diagnosis, and Dr. Ossai’s work bridged a crucial knowledge gap in operational diagnostics. Importantly, his research confirmed that no specific socio-demographic factor significantly influenced the error outcomes, suggesting that systemic training and technological interventions would yield better diagnostic consistency. His dedication to improving point-of-care TB diagnostics reflects a forward-thinking research agenda. By focusing on real-world implementation, Dr. Ossai champions the evolution of diagnostic technologies like Truenat as scalable, reliable tools against Tuberculosis in both urban and rural health settings.

COLLABORATIVE CONTRIBUTIONS 🤝 | TEAMING UP FOR TUBERCULOSIS

Tuberculosis control is a multidisciplinary challenge, and Dr. Edmund Ndudi Ossai has consistently worked within collaborative frameworks to ensure robust, real-world impact. His Truenat project involved experts from the Federal Ministry of Health, USAID Nigeria, KNCV Nigeria, the Stop TB Partnership in Geneva, and international consultants. The team, composed of public health officials, data analysts, and diagnostic specialists, operated across 38 Truenat sites in Nigeria. This cross-functional synergy was pivotal in uncovering diagnostic inefficiencies and optimizing the TB testing ecosystem. Dr. Ossai’s ability to coordinate among various stakeholders helped harmonize the technical objectives with national health priorities. Tuberculosis remains a complex epidemic demanding synchronized intervention, and his collaborative model served as a blueprint for successful scale-up strategies. He also emphasized capacity building by proposing improvements in the Truenat training curriculum—ensuring that laboratory personnel are better equipped to manage error codes and machine anomalies. His collaborative ethos not only enhanced data quality and study execution but also cultivated a spirit of shared ownership, which is crucial for sustainable Tuberculosis program outcomes. These partnerships significantly magnified the study’s implications and laid the groundwork for policy reform in diagnostic practices across Nigeria.

IMPACT AND INFLUENCE 🌍 | SHAPING TUBERCULOSIS STRATEGIES

Dr. Edmund Ndudi Ossai’s research has had a lasting impact on Nigeria’s Tuberculosis control policies. His findings from the Truenat pilot study have reshaped how diagnostic errors are interpreted and addressed at the health facility level. By identifying the frequency and distribution of errors, his work has provided a practical framework for the Federal Ministry of Health to enhance TB diagnostic protocols. Tuberculosis diagnosis in resource-limited settings often suffers from a lack of precision and operational feedback loops. Dr. Ossai’s influence has shifted this narrative toward data-driven interventions. Health facilities that once struggled with unclear error sources now benefit from standardized processes informed by his research. His call for revising the national Truenat training curriculum has already sparked conversations among policymakers, potentially improving laboratory performance on a large scale. Beyond institutional settings, his research has influenced public health discourse on integrating technology into infectious disease control. By emphasizing low error rates and practical improvements, Dr. Ossai’s work reassures stakeholders of Truenat’s potential in scaling TB detection. The ripple effects of his contributions are seen in better diagnostics, timely treatment, and a reinvigorated approach to combating Tuberculosis in Nigeria.

ACCOLADES AND RECOGNITION 🏅 | TUBERCULOSIS CHAMPION

For his relentless contributions to Tuberculosis diagnostics and public health research, Dr. Edmund Ndudi Ossai has garnered respect from academic, clinical, and governmental circles. While not all of his accolades may be publicly listed, the recognition of his work in influential studies such as the Truenat implementation speaks volumes. Being a lead investigator on a national-level study involving over 56,000 samples places him in the top tier of Nigeria’s TB researchers. His affiliations with prestigious institutions like Ebonyi State University and his collaborations with global health entities signal the esteem in which he is held. Tuberculosis remains a pressing issue, and contributors like Dr. Ossai are celebrated not just for publishing results, but for providing real solutions. The study he authored has already influenced training, policy, and practice—tangible outcomes that serve as their own form of recognition. His work has likely inspired a new generation of public health professionals who see research not just as academic output, but as a tool for systemic transformation. In the battle against Tuberculosis, Dr. Ossai’s research has earned him the role of a thought leader and innovator.

LEGACY AND FUTURE DIRECTIONS 🚀 | ADVANCING TUBERCULOSIS SOLUTIONS

Looking ahead, Dr. Edmund Ndudi Ossai’s legacy is poised to expand through ongoing research and policy engagement in Tuberculosis diagnostics. His foundational work with Truenat testing has set the stage for larger, more sophisticated investigations into diagnostic reliability and field-level operationalization. With Nigeria planning to scale up the Truenat platform, Dr. Ossai’s insights will be crucial in minimizing diagnostic errors and improving turnaround time. His legacy will also be cemented through future revisions of the Truenat training curriculum, a key recommendation from his study. Moreover, his influence may extend into digital health integration, where mobile data capture and remote machine monitoring could further reduce TB diagnostic delays. Tuberculosis control is evolving, and Dr. Ossai’s future role might include developing national guidelines, mentoring emerging researchers, and participating in global TB eradication initiatives. His ability to translate field data into actionable strategies ensures that his legacy isn’t static—it’s a growing force in public health. For communities long burdened by Tuberculosis, the long-term impact of Dr. Ossai’s work represents hope, innovation, and sustained progress toward eradication.

NOTABLE PUBLICATION

  • Title: Prevalence of hypertension and associated factors among residents of Ibadan-North Local Government Area of Nigeria
    Authors: IO Ajayi, IO Sowemimo, OM Akpa, NE Ossai
    Journal: Nigerian Journal of Cardiology

  • Title: Specialty preferences among final year medical students in medical schools of southeast Nigeria: need for career guidance
    Authors: EN Ossai, KA Uwakwe, UC Anyanwagu, NC Ibiok, BN Azuogu, N Ekeke
    Journal: BMC Medical Education

  • Title: Retention in care and adherence to HIV and AIDS treatment in Anambra State Nigeria
    Authors: CD Umeokonkwo, CA Onoka, PA Agu, EN Ossai, MS Balogun, et al.
    Journal: BMC Infectious Diseases

  • Title: Predictors of practice of breast self-examination: A study among female undergraduates of Ebonyi State University, Abakaliki, Nigeria
    Authors: EN Ossai, BN Azuogu, IO Ogaranya, AI Ogenyi, DO Enemor, MA Nwafor
    Journal: Nigerian Journal of Clinical Practice

  • Title: Physician burnout in Nigeria: a multicentre, cross-sectional study
    Authors: ADG Nwosu, EN Ossai, UC Mba, I Anikwe, R Ewah, BO Obande, et al.
    Journal: BMC Health Services Research

Hanzhen Qiao – Hepatitis – Best Research Article Award

Published on by Infectious

Hanzhen Qiao - Hepatitis - Best Research Article Award

Henan University of Technology - China

AUTHOR PROFILE

SCOPUS

EARLY ACADEMIC ROOTS 🌱

Dr. Qiao Hanzhen’s academic foundation was rooted in a passion for food science and biotechnology. He laid the groundwork for his research career with advanced degrees, culminating in a Ph.D. that emphasized biochemical and functional food components. From his early educational experiences, Dr. Qiao demonstrated a strong curiosity about the natural healing potential of traditional Chinese ingredients. This intellectual pursuit paved the way for exploring herbal remedies not only for nutritional benefits but also for their pharmacological applications in managing chronic illnesses like Hepatitis. The intersection of natural compounds and liver health became a subtle yet significant thread in his early studies. His educational background is emblematic of a broader scientific movement aiming to bridge Eastern medicinal knowledge with modern biomedical science. During his formative academic years, he gained the analytical tools to investigate complex biological interactions and gained exposure to research methodologies that would later become central to his work on Chinese herbal extracts. These skills equipped him to contribute to new approaches in supporting hepatic functions through dietary interventions. By embedding his early learning in multidisciplinary research, Dr. Qiao built a robust academic identity, positioning him well for impactful contributions to the study and treatment of conditions such as Hepatitis.

PROFESSIONAL ENDEAVORS & LEADERSHIP 👨‍🏫

Currently an Associate Professor at Henan University of Technology, Dr. Qiao Hanzhen has steadily risen as a formidable academic leader. As a Master's Supervisor and Young Backbone Teacher of Henan Province, he mentors students across disciplines, fostering innovation in food science and natural product development. His extensive participation in academic committees—including the Feed Branch of the China Cereals, Oils and Foodstuffs Association and the Henan Feed Industry Association—demonstrates his active role in shaping national food and feed policies. Under his leadership, more than ten key projects have been successfully implemented, reflecting his credibility and expertise. His role in provincial and national research schemes reflects a growing interest in sustainable feed development and the health implications of dietary additives. Among his targeted areas is the effect of herbal bioactives on liver function and immunity, tying directly into therapeutic research involving Hepatitis. Dr. Qiao’s leadership transcends teaching, serving as a bridge between theoretical research and practical applications. His research labs often serve as testing grounds for plant-based innovations, some with promising hepatoprotective outcomes. These initiatives contribute to a broader vision: enhancing health through nutritional interventions, particularly for chronic diseases like Hepatitis, by building better scientific frameworks for herbal efficacy.

RESEARCH FOCUS ON HERBAL EXTRACTS & FUNCTIONAL FOODS 🌿

At the core of Dr. Qiao Hanzhen’s scholarly contributions is a dedicated focus on Chinese herbal extracts and their functional evaluation. His work investigates the bioactive compounds present in native botanicals and their potential roles in enhancing human health, especially in modulating liver function and immunity. His projects span a variety of herbs traditionally used in Chinese medicine, aimed at supporting bodily resilience against oxidative stress and inflammation. One recurring application of these studies is their relevance to hepatology. Hepatitis, being a liver-centered condition, often demands supportive therapies that mitigate liver damage—an area where herbal-based interventions have shown increasing promise. Dr. Qiao’s lab has examined the antioxidant, anti-inflammatory, and detoxifying properties of numerous plant extracts, some of which display potential as adjunct therapies for Hepatitis management. These functional foods are not merely nutritional; they possess properties that may influence biological pathways related to hepatic health. His interdisciplinary research integrates elements of pharmacognosy, nutritional biochemistry, and food technology. The innovative edge lies in using these herbs in feed additives, supplements, or functional beverages, thus expanding the scope of preventive health. Dr. Qiao's focused commitment to herbal science situates him as a leader in researching novel methods to address liver diseases, including Hepatitis.

CONTRIBUTIONS TO NATIONAL & INTERNATIONAL RESEARCH 🌍

Dr. Qiao Hanzhen has made significant contributions to both national and international scientific communities through collaborative research and scholarly publications. He has led or participated in over ten major projects, including prestigious grants under the National Key R&D Program of China’s 14th Five-Year Plan. His involvement in such high-level initiatives indicates both his technical competence and strategic vision. These programs often integrate research themes focused on public health, feed safety, and plant-derived therapeutic agents—some explicitly addressing inflammatory liver conditions like Hepatitis. His work has appeared in respected journals such as Food Chemistry and Antioxidants, reflecting peer recognition across scientific domains. With over 30 peer-reviewed publications, Dr. Qiao has built a body of literature that supports the clinical relevance of natural products. He is a co-author of seven textbooks and has developed two national standards, setting guidelines that may impact future food or herbal product regulation. His research outputs consistently emphasize the importance of evidence-based use of herbs in mitigating conditions such as Hepatitis. By marrying fundamental research with applied science, he continues to influence how we perceive traditional remedies in modern contexts, ensuring their credible inclusion in future therapeutic discussions—especially for hepatic disorders like Hepatitis.

PATENTS, TEXTBOOKS & TECHNICAL ADVANCEMENTS 📘

Innovation forms the backbone of Dr. Qiao Hanzhen’s academic ethos, as reflected in his intellectual property contributions and technical publications. He has filed six patents, one of which has been granted, showcasing novel methodologies or compounds related to herbal extract formulations. These inventions often revolve around natural feed additives or functional food ingredients that may support liver metabolism or possess anti-inflammatory benefits. In parallel, Dr. Qiao has co-authored seven textbooks, serving as essential references for students and professionals in food science, herbal pharmacology, and biotechnology. These educational resources include knowledge drawn from his work on botanical agents and their role in preventing or alleviating diseases like Hepatitis. His national standards development further amplifies his impact, translating research findings into practical, regulated applications. These contributions serve not only academic purposes but also industrial, offering scientifically validated models for herbal product formulation. His technical achievements ensure that the next generation of researchers and practitioners can build upon validated knowledge frameworks, especially in contexts where hepatic health and Hepatitis prevention are public health priorities. Through these enduring academic outputs, Dr. Qiao secures his position as both a knowledge creator and a systems innovator.

RECOGNITION & SCIENTIFIC ACCLAIM 🏅

Recognition for Dr. Qiao Hanzhen’s pioneering work has come through prestigious accolades, most notably the First Prize of the Henan Province Science and Technology Achievement Award. This honor reflects peer and governmental acknowledgment of his sustained contributions to research and societal advancement. The award recognizes his innovation in applying Chinese herbal extracts to improve both feed efficiency and public health—a dual benefit especially relevant in areas grappling with food security and chronic diseases. Among these diseases, Hepatitis figures prominently due to its global prevalence and demand for long-term, non-toxic management strategies. Dr. Qiao’s reputation has also grown through active participation in professional associations, enabling policy engagement and research dissemination. His recognition extends beyond borders through collaborations and citations in international research. Such acclaim has strengthened the visibility of his work on hepatic health and botanical interventions. As the world increasingly turns to integrative approaches for disease management, awards like these endorse Dr. Qiao’s research path as both visionary and practical. They affirm the significance of natural solutions in modern health crises, including the pressing need for innovative adjunct treatments for Hepatitis using food-based and botanical interventions grounded in empirical evidence.

FUTURE DIRECTIONS & LASTING LEGACY 🔬

Looking forward, Dr. Qiao Hanzhen’s legacy is poised to influence both academic and clinical landscapes. His future directions involve expanding the use of Chinese herbal extracts into mainstream therapeutic applications, particularly targeting liver-related conditions such as Hepatitis. He envisions a research ecosystem that marries traditional medicinal wisdom with high-throughput screening technologies, enabling the rapid identification of plant-based agents for disease intervention. His mentorship of graduate students ensures the continuation of this research philosophy, embedding sustainability and public health impact into the heart of future scientific inquiry. Additionally, Dr. Qiao plans to refine the molecular mechanisms behind herbal effects on hepatic cells, with the aim of translating these findings into functional food products and dietary supplements. These innovations could one day become complementary therapies for chronic liver ailments, including Hepatitis, offering safer and culturally relevant alternatives to synthetic drugs. His work also sets the stage for more interdisciplinary collaboration between food scientists, medical researchers, and policy makers. Dr. Qiao’s career trajectory and research vision underscore the importance of integrative medicine in future health solutions, establishing a legacy that bridges traditional knowledge and contemporary science—particularly in the enduring fight against Hepatitis.

NOTABLE PUBLICATION

  • Title: Impacts of zinc caproate supplementation on growth performance, intestinal health, anti-inflammatory activity, and Zn homeostasis in weaned piglets challenged with Escherichia coli K88
    Authors: Not specified in your message (likely multiple authors; can be retrieved from the journal site)
    Journal: Journal of Animal Science and Biotechnology
    Year: 2025

 

  • Title: Anti-inflammatory effects of Rehmannia glutinosa polysaccharide on LPS-induced acute liver injury in mice and related underlying mechanisms
    Authors: Not specified in your message
    Journal: Journal of Ethnopharmacology
    Year: 2025

 

  • Title: Andrographolide protects against the intestinal barrier dysfunction and inflammatory response through modulating ETEC virulence factors in a mouse model of diarrhea
    Authors: Not specified in your message
    Journal: Journal of Functional Foods
    Year: 2024

Expedito Luna – Infectious Diseases Vaccines – Best Researcher Award

Published on by Infectious

Expedito Luna - Infectious Diseases Vaccines - Best Researcher Award

USP - Brazil

AUTHOR PROFILE

ORCID

EARLY ACADEMIC ROOTS 🌱

Dr. Expedito J.A. Luna's foundational journey in medicine began with a Medical Degree (M.D.) from the Universidade Federal de Pernambuco in 1981, followed by a Medical Residency in Preventive Medicine at the Universidade de São Paulo. His academic path was further enriched with a Master's in Public Health from Universidade Estadual de Campinas and a Ph.D. in Preventive Medicine/Epidemiology from the University of São Paulo. From the start, his scholarly interest gravitated toward epidemiology and public health, especially in the control and surveillance of communicable diseases. These formative years laid the groundwork for his lifelong dedication to combating health crises in Brazil and beyond. Driven by a commitment to vulnerable populations and the scientific potential of Immunoprevention, he was particularly focused on how evidence-based strategies, like Infectious Diseases Vaccines, could curb epidemics and improve public health outcomes. This academic preparation would later empower him to take on high-level responsibilities in both government and academia, ultimately leading to impactful leadership roles. His passion for rigorous training and empirical analysis equipped him to become a recognized authority in the field. Thus, Dr. Luna’s early academic pursuits served as the launchpad for a distinguished career focused on public health innovation and Infectious Diseases Vaccines.

EARLY ACADEMIC ROOTS 🌱

Dr. Expedito J.A. Luna's foundational journey in medicine began with a Medical Degree (M.D.) from the Universidade Federal de Pernambuco in 1981, followed by a Medical Residency in Preventive Medicine at the Universidade de São Paulo. His academic path was further enriched with a Master's in Public Health from Universidade Estadual de Campinas and a Ph.D. in Preventive Medicine/Epidemiology from the University of São Paulo. From the start, his scholarly interest gravitated toward epidemiology and public health, especially in the control and surveillance of communicable diseases. These formative years laid the groundwork for his lifelong dedication to combating health crises in Brazil and beyond. Driven by a commitment to vulnerable populations and the scientific potential of Immunoprevention, he was particularly focused on how evidence-based strategies, like Infectious Diseases Vaccines, could curb epidemics and improve public health outcomes. This academic preparation would later empower him to take on high-level responsibilities in both government and academia, ultimately leading to impactful leadership roles. His passion for rigorous training and empirical analysis equipped him to become a recognized authority in the field. Thus, Dr. Luna’s early academic pursuits served as the launchpad for a distinguished career focused on public health innovation and Infectious Diseases Vaccines.

PROFESSIONAL ENDEAVORS 🏥

Dr. Expedito J.A. Luna’s professional trajectory is marked by decades of service in Brazil’s public health system. He began his work at the State of São Paulo Health Secretariat and later served at the Municipal Health Secretariat. His career then advanced to the national level, where he became Director of the Department of Surveillance and Control of Communicable Diseases at the Ministry of Health. In these roles, he was instrumental in implementing large-scale epidemiological programs targeting vaccine-preventable illnesses and neglected tropical diseases. He brought a scientific mindset and operational discipline to the management of epidemics, working to integrate surveillance, diagnostics, and vaccine strategies. His efforts had a measurable impact on national health metrics, especially in reducing the burden of diseases through expanded immunization campaigns. He also served as a scientific advisor to national STI and AIDS programs, showing the breadth of his public health influence. These professional chapters reflect his commitment to translating data into action and policy. Throughout his career, he has emphasized the importance of scientific evidence in health decision-making, especially around Infectious Diseases Vaccines, which he consistently promoted as a cornerstone of disease prevention and control strategies across Brazil’s healthcare infrastructure.

RESEARCH EXCELLENCE & FOCUS 🔬

A cornerstone of Dr. Luna’s legacy is his prolific research in epidemiology, with a particular focus on vaccine effectiveness and disease surveillance. His academic base at the Institute for Tropical Medicine at the University of São Paulo has been a launchpad for numerous groundbreaking studies. From COVID-19 and dengue to influenza and Zika, he has led or participated in over 30 funded research projects. His investigations often center on the real-world effectiveness of Infectious Diseases Vaccines, including CORONAVAC, influenza, rotavirus, yellow fever, and tetravalent dengue vaccines. He has received grants from esteemed institutions such as FAPESP, CNPq, the Ministry of Health, and international organizations like the Mérieux Foundation and Sanofi. Many of his studies use test-negative case-control designs or cohort approaches to measure vaccine performance in diverse populations, including healthcare workers, pregnant women, and indigenous communities. His work bridges field epidemiology with laboratory science, often addressing disease prevalence, transmission dynamics, and immunological response. Dr. Luna’s research not only advances academic knowledge but also informs national immunization policies. With hundreds of peer-reviewed publications, his data-driven insights have reinforced the critical role of Infectious Diseases Vaccines in managing Brazil’s—and the region’s—public health challenges.

POLICY INFLUENCE & LEADERSHIP 📊

Dr. Luna has played a pivotal role in shaping Brazil’s public health policy, particularly in infectious disease control and immunization programs. His tenure as Director of the Department of Surveillance and Control of Communicable Diseases at the Ministry of Health was marked by significant advancements in national disease prevention strategies. He oversaw large-scale surveillance systems and contributed to the development and evaluation of national vaccine policies, ensuring their alignment with scientific findings. His leadership was vital in coordinating efforts to contain outbreaks of dengue, influenza, Zika, and other emerging threats. He also contributed to global discussions on vaccine strategy and safety, as seen in his co-authorship of influential papers on post-licensure vaccine evaluation. His guidance extended to the National Vaccine Coverage Survey and maternal vaccination initiatives, which were instrumental in protecting vulnerable groups. Dr. Luna's ability to bridge academia and policy-making set a gold standard for evidence-based governance. His focus on Infectious Diseases Vaccines positioned him as a trusted voice in both domestic and international forums. Through his leadership, Brazil has seen greater coherence between scientific discovery and public health application, enhancing the reach and effectiveness of vaccination as a tool for disease control.

TEACHING & MENTORSHIP 📚

Beyond his public health and research contributions, Dr. Luna has nurtured the next generation of epidemiologists as a professor at the University of São Paulo’s Institute for Tropical Medicine. Since 2008, he has played an integral role in training medical students, public health professionals, and postgraduate scholars in infectious disease epidemiology. His courses emphasize critical thinking, data interpretation, and the application of epidemiological methods to real-world problems. He brings field experience into the classroom, enriching academic learning with practical insights. Dr. Luna also mentors young researchers through thesis supervision and research collaboration, many of whom now hold influential positions in public health across Brazil. He is renowned for promoting interdisciplinary learning, encouraging students to explore links between clinical outcomes, environmental factors, and population health. Central to his pedagogy is the pivotal role of Infectious Diseases Vaccines in disease prevention. His mentorship approach is not only academic but also aspirational, instilling a sense of duty and purpose among his mentees. Through his teaching, Dr. Luna ensures that the values of scientific rigor, public health advocacy, and vaccine equity continue to influence Brazil’s healthcare landscape for years to come.

RECOGNITION & ACCOLADES 🏆

Throughout his distinguished career, Dr. Expedito J.A. Luna has earned widespread recognition for his contributions to public health and epidemiology. His efforts have been celebrated not just within Brazil but also in international forums, owing to his collaborative work with organizations like the World Health Organization, Pan American Health Organization, and various global health research foundations. His publications in high-impact journals, ranging from The Lancet to Vaccine and BMJ Open, underscore the scholarly depth and policy relevance of his work. As a principal investigator on critical national studies, including those assessing vaccine coverage, effectiveness, and disease prevalence, Dr. Luna has received prestigious research grants and institutional support across decades. His influence has been instrumental in developing and evaluating policies that continue to shape national immunization strategies. Among his most valuable recognitions is the trust placed in him by Brazil’s Ministry of Health to direct nationwide programs during times of crisis. Across all honors, one theme remains consistent: his unwavering commitment to advancing Infectious Diseases Vaccines as a primary defense against public health threats. Dr. Luna’s accolades are a testament to his lasting impact on science, policy, and population health.

IMPACT & GLOBAL COLLABORATION 🌎

Dr. Luna’s work transcends borders, exemplifying the global nature of public health. Through cross-national research collaborations and policy consulting, he has contributed to a broader understanding of how infectious diseases emerge, spread, and can be controlled through vaccination. His involvement in studies on dengue, influenza, and COVID-19 has provided comparative insights applicable across Latin America and beyond. He has co-authored international papers addressing vaccine strategies, transmission models, and post-licensure evaluations. Dr. Luna’s voice is regularly sought in global forums focused on Infectious Diseases Vaccines, where he shares Brazil’s experiences and learns from global peers. His collaboration with organizations like WHO and PAHO has influenced vaccine rollout strategies and disease surveillance models. He also contributes to international training programs, strengthening capacity in low-resource settings. By advocating for equitable vaccine access and evidence-based interventions, Dr. Luna has helped shape a more unified and proactive global public health response. His legacy extends to influencing vaccine policies not only in Brazil but in other countries that have modeled their strategies after his data-driven approaches. Through this global footprint, he reinforces the indispensable role of Infectious Diseases Vaccines in achieving worldwide health security.

LEGACY & FUTURE VISION 🔮

As Dr. Luna continues his work at the University of São Paulo, his vision for the future remains grounded in scientific advancement and public health equity. He envisions a world where data-driven policies, robust surveillance, and universal access to effective vaccines are the norm rather than the exception. His ongoing projects focus on vaccine effectiveness, particularly for COVID-19 and dengue, reaffirming his belief in the central role of Infectious Diseases Vaccines in combating evolving health threats. He remains deeply involved in guiding young scientists and contributing to research that influences national immunization programs. Looking ahead, he advocates for stronger integration of epidemiological data with digital health tools to improve outbreak detection and response. His legacy lies not only in the programs he helped build or the research he led but also in the public health mindset he helped instill in Brazil and beyond. By continuing to engage with policy-makers, research bodies, and students, Dr. Luna ensures that the next generation will carry forward the torch of scientific integrity and vaccine-driven disease control. His work serves as a blueprint for future epidemiologists seeking to leverage Infectious Diseases Vaccines for a healthier, more resilient world.

NOTABLE PUBLICATION 

  • Title: A spatial case-control study on symptomatic and inapparent primary dengue infections in an endemic city in Brazil
    Authors: Gerusa Figueiredo, Francisco Chiaravalloti, Sérgio Campos, Alessandra Cristina Guedes Pellini, Alvina Clara Felix, Expedito Luna
    Journal: Revista do Instituto de Medicina Tropical de São Paulo
    Year: 2024

 

  • Title: Detection of Internal Transcribed Spacer 1 and hsp70 Genetic Markers Using Restriction Fragment Length Polymorphisms and Sequencing in Identification of Leishmania Species Causing Tegumentary Leishmaniasis in Brazil
    Authors: J.A. Delprete, L.V. de Almeida, A.M. Barros, R.D.C. Soler, A.A. Bittencourt, E.J. de Albuquerque Luna, J.A.L. Lindoso, L.M.A. Braz
    Journal: American Journal of Tropical Medicine and Hygiene
    Year: 2024

 

  • Title: Dynamics of communication on measles vaccination on digital platforms in the Brazilian context: challenges and perspectives
    Authors: Maria da Penha Soares Silva, Vera Lúcia Gattás, Expedito José de Albuquerque Luna
    Journal: Revista do Instituto de Medicina Tropical de São Paulo
    Year: 2024

 

  • Title: Low vaccine coverage and varicella outbreaks in Brazil − 2019–2022
    Authors: D.M. Fujita, L.H. da Silva Nali, R.R. da Costa, H.F. de Andrade Júnior, E.J. de Albuquerque Luna
    Journal: Vaccine
    Year: 2024

 

  • Title: Phylogenetics, Epidemiology and Temporal Patterns of Dengue Virus in Araraquara, São Paulo State
    Authors: C.S. de Souza, G.S. Caleiro, I.M. Claro, J.G. de Jesus, T.M. Coletti, C.A.M. da Silva, Â.A. Costa, M. Inenami, A.C. Ribeiro, A.C. Felix et al.
    Journal: Viruses
    Year: 2024

Moncef Chouaibi – Treatment for Infectious Diseases – Best Academic Researcher Award

Published on by Infectious

Moncef Chouaibi - Treatment for Infectious Diseases - Best Academic Researcher Award 

Higher School of Food Industries of Tunis - Tunisia

AUTHOR PROFILE

ORCID

🎓 EARLY ACADEMIC PURSUITS

Professor Moncef Chouaïbi's academic journey reflects a strong foundation in mathematical sciences and food engineering. He began with a Bachelor of Mathematics from 1996 to 2000, which laid the groundwork for his analytical approach in later scientific explorations. He pursued an engineering diploma, master’s, and ultimately a PhD in Food Industries between 2000 and 2013 from the University of Carthage and the University of Salerno. His doctoral studies focused on food engineering and preservation technologies, critical to public health, especially in regions facing foodborne infections. During these formative years, he developed a keen interest in the optimization of extraction processes, thermal food treatment, and encapsulation of bioactive compounds—techniques that today underpin innovations in antimicrobial food systems. His early academic path emphasized both theoretical mastery and applied research, equipping him with the scientific literacy and lab-based expertise to address complex problems in food safety and infectious disease management. His studies incorporated methodologies that enhance food functionality while limiting pathogen transmission—a core concern in infectious disease control. This period was not just a phase of learning but also a springboard for his later contributions to microbiologically safe and nutritionally enhanced food products.

🧪 PROFESSIONAL ENDEAVORS IN FOOD SCIENCE

Since the early stages of his career, Professor Chouaïbi has devoted himself to the advancement of food engineering with a strong focus on safety, stability, and nutrition. Starting as a Senior Research Fellow in Tunis and later in Salerno, Italy, he quickly transitioned into academic leadership as an Assistant Professor and eventually as a full Professor at the Higher School of Food Industries of Tunis. His teaching and mentoring have supported a new generation of scientists, but it is his research that sets him apart. He has actively explored the use of natural preservatives, bioactive components, and rheological food properties to improve food quality and safety. This work is especially relevant in developing countries where infectious diseases are often exacerbated by compromised food systems. By modeling heat and mass transfer, Professor Chouaïbi has helped design preservation techniques that reduce microbial load in food, directly contributing to infectious disease prevention. He has also collaborated with biotechnology and food chemistry experts to create functional foods that boost immune responses. His hands-on approach and strategic focus on real-world applications of food science make his professional journey a beacon for interdisciplinary innovation in nutrition and public health.

🧬 RESEARCH ON FUNCTIONAL FOODS & BIOACTIVE COMPOUNDS

Professor Moncef Chouaïbi has established himself as a pioneering researcher in the field of functional foods and bioactive compound extraction. His studies on antioxidant-rich oils, including those derived from pumpkin, celery, and Zizyphus lotus, demonstrate his commitment to exploring nature-derived solutions to public health challenges. Many of these compounds, such as polyphenols and flavonoids, have demonstrated antimicrobial and antiviral properties, making them potential adjuncts in infectious disease treatment. His innovative work on encapsulation technology—particularly nanoemulsions and double emulsions—has enabled targeted delivery of these compounds, enhancing their stability and efficacy. These advances have broad implications in the management of bacterial and viral foodborne illnesses, especially in vulnerable populations. His research is widely published in high-impact journals, evidencing both depth and breadth. Through projects like yogurt fortified with inulin or camel milk enhanced with probiotics, he combines scientific rigor with nutritional foresight. His exploration of shelf-life enhancement and preservation methods directly addresses contamination and disease spread in perishable goods. Such applications play a crucial role in food systems resilience against pathogens, including those that cause enteric infections. His work positions food not only as sustenance but as a strategic platform for disease intervention.

🧫 ADVANCES IN INFECTIOUS DISEASE TREATMENT VIA FOOD SCIENCE

Professor Chouaïbi's contributions have extended beyond traditional food science into the realm of infectious disease treatment and prevention. His application of bioactive-rich emulsions and coatings—such as thyme essential oil encapsulation and almond gum films—offers a sustainable, chemical-free alternative to conventional disinfectants. These formulations are especially effective against microbial spoilage and contamination, which are common vectors for infectious disease transmission through food. His collaborations have resulted in yogurt enriched with antimicrobial agents and functional cheeses with targeted probiotic properties, both of which support gastrointestinal health and immunological defense. His work on modeling urease activity reduction in soybean meals and optimizing drying processes has clinical relevance in reducing pathogen viability. Furthermore, his patents on emulsifiers and encapsulation systems are setting new standards in controlled delivery of anti-pathogenic agents. As diseases evolve and antibiotic resistance grows, the integration of food engineering in the fight against infections becomes increasingly vital. Through his food-based biotechnological innovations, Professor Chouaïbi is contributing practical tools that align nutrition with infection control, reinforcing the interdisciplinary bridge between food technology and public health.

📚 EDITORIAL AND SCHOLARLY IMPACT

Beyond research and teaching, Professor Chouaïbi holds influential editorial roles in several international journals including Discover Food, Journal of Food Measurement and Characterization, and Frontiers in Materials. These positions affirm his global recognition as an authority in food engineering. His role as guest editor and board member enables him to shape emerging discourses around sustainable food systems, food safety, and biofunctional ingredients. He has authored multiple books and book chapters that explore food preservation technologies, phytochemicals, and encapsulation techniques—many of which serve as reference texts in food and nutrition science. His scholarly contributions provide critical frameworks for understanding how food technology can mitigate microbial risks. Through peer review and journal leadership, he fosters innovation, ensures scientific rigor, and promotes cross-border collaborations. This academic leadership enhances not just his personal standing but also the integrity and visibility of food science research in developing infectious disease interventions. By mentoring young scientists and influencing research directions globally, Professor Chouaïbi multiplies his impact, ensuring the continuity and evolution of science-based solutions to pressing health threats.

🏆 HONORS, PATENTS & INTERNATIONAL COLLABORATIONS

Professor Moncef Chouaïbi’s excellence has been acknowledged through various honors, patents, and extensive international engagements. He is a patent holder for technologies including novel emulsifiers for drug delivery and food coating systems with bioactive properties, which support food safety and infectious disease mitigation. These innovations provide scalable solutions for controlling contamination in food supply chains. His scientific influence spans across borders with collaborative research in Italy, Japan, and across North Africa. Participation in international conferences—from the Euro-Global Conference on Food Science to Japan-Tunisia symposia—underscores his reputation as a global expert. His patented work on the use of natural polymers and biopolymers in preserving food integrity has found use in both academic and industrial settings. These achievements not only validate his research but also position his methodologies as models for innovation in developing antimicrobial systems from food matrices. His multidisciplinary patents have crossover value in pharmaceuticals, nutraceuticals, and environmental safety. These accolades represent the fusion of his engineering ingenuity with a vision for healthier communities.

🌍 LEGACY & FUTURE CONTRIBUTIONS TO GLOBAL HEALTH

Looking ahead, Professor Chouaïbi is poised to further integrate food engineering with global health initiatives. His future research aims to refine nanoencapsulation methods to deliver targeted nutritional therapies and anti-infective agents through everyday food products. His commitment to addressing malnutrition, microbial contamination, and diet-related diseases aligns with global health goals and sustainable development frameworks. By developing bioactive-rich ingredients from agricultural waste, he also promotes circular economy principles and food system sustainability. His work resonates deeply in low- and middle-income countries, where accessible, nutrition-based interventions are critical in combating infectious disease burdens. As a mentor and innovator, his legacy will extend through the scientists he inspires, the institutions he shapes, and the communities that benefit from his science. With over 50 peer-reviewed articles and involvement in cutting-edge international projects, Professor Chouaïbi's contribution to the intersection of food science and infectious disease control is both transformative and enduring. His vision positions food not just as nourishment, but as a strategic frontier in the fight against infectious diseases worldwide.

NOTABLE PUBLICATION

  • Title: Co-encapsulation of catechin and L-lysine in water-in-oil-in-water (W1/O/W2) double emulsion using membrane emulsification process: application in carrot based infant-purée
    Authors: Eya Soussi, Nayrouz Yahyaoui, Moncef Chouaibi, Salem Hamdi
    Journal: Journal of Food Measurement and Characterization
    Year: 2025

 

  • Title: Comparative study of Acacia tortilis subsp. raddiana gum of Tunisian origin and commercial Acacia senegal gum
    Authors: Khouloud Rigane, Moncef Chouaibi, Romdhane Karoui
    Journal: Journal of Food Measurement and Characterization
    Year: 2025

 

  • Title: Arbutus unedo fruit syrup as a fortifying agent: effect on physicochemical, microbiological, rheological, sensory and antioxidant properties of yoghurt
    Authors: I. Essaidi, M. Chouaibi, H. Haj Koubaier, S. Bouacida, A. Snoussi, Y. Abassi, N. Bouzouita
    Journal: Journal of Food Science and Technology
    Year: 2023

 

  • Title: Bioactive Phytochemicals from Pumpkin Seed Oil Processing By-products
    Authors: L. Rezig, K. Gharsallah, M. Chouaibi
    Journal: Reference Series in Phytochemistry (Book Chapter)
    Year: 2023

 

  • Title: Influence of Conservation Agriculture on Durum Wheat Grain, Dough Texture Profile and Pasta Quality in a Mediterranean Region
    Authors: I. Kerbouai, D. Sfayhi, K. Sassi, H.C. M’hamed, H. Jenfaoui, J. Riahi, S. Arfaoui, M. Chouaibi, Ben-... (author name appears truncated)
    Journal: Agriculture (Switzerland)
    Year: 2023

Mohamed Abdel-Rahim – Zoonosis – Best Researcher Award

Published on by Infectious

Mohamed Abdel-Rahim - Zoonosis - Best Researcher Award

National Institute of Oceanography and Fisheries (NIOF) - Egypt

AUTHOR PROFILE 

ORCID

🌊 ACADEMIC FOUNDATION IN AQUATIC SCIENCE

Dr. Mohamed M. Abdel-Rahim laid the bedrock of his scientific journey at the University of Alexandria, where he earned his B.Sc., M.Sc., and Ph.D. in Aquaculture with distinction. With a persistent drive for excellence, his educational background immersed him in marine biology, aquaculture systems, and aquatic animal health—fields critical for understanding zoonotic risks in aquatic environments. His early research explored aquaculture engineering and fish reproduction, equipping him with both technical mastery and biological insight. This academic rigor formed the foundation for his future contributions to the management of aquatic ecosystems, fish diseases, and food safety, which are all central to zoonosis prevention in aquaculture. As zoonotic diseases increasingly emerge from aquatic sources due to intensified aquaculture practices, Dr. Abdel-Rahim’s work in environmental monitoring, hatchery design, and water quality management positions him as a vital player in sustainable fish production and health risk mitigation. Through advanced courses in Spain and France, he also honed his understanding of environmental impacts and modern aquaculture technologies. This academic foundation allowed him to interface between ecosystem health and public safety, setting the stage for lifelong contributions to aquaculture science and zoonotic disease control in aquatic systems.

🔬 SCIENTIFIC INNOVATIONS AND RESEARCH PURSUITS

Dr. Mohamed M. Abdel-Rahim’s research legacy is marked by groundbreaking innovations in sustainable aquaculture and aquatic health, focusing on preventing zoonosis through improved farming systems. As Principal Investigator and team member on numerous projects funded by NIOF and international bodies, he has tackled challenges in marine aquaculture, water purification, biofloc technology, and fish nutrition. Notably, his work on recirculating aquaculture systems (RAS) and Integrated Multi-Trophic Aquaculture (IMTA) models highlights his role in minimizing the environmental and biological risks that contribute to zoonotic transmission. His peer-reviewed publications—over 55 in high-impact journals—span topics from bacterial load reduction to the use of herbal immunostimulants and probiotics in fish diets, directly addressing disease resistance and food safety. Dr. Abdel-Rahim’s focus on fish health and immunity builds a crucial bridge to zoonotic disease prevention, especially in densely stocked aquatic farms where pathogen transfer between species and humans is possible. His use of natural additives and innovative feed strategies further ensures healthier aquaculture products, aligning food security with public health. These contributions are not just technical—they’re visionary, establishing protocols that integrate sustainability, economics, and zoonotic risk reduction within modern aquaculture systems.

🧪 EDUCATION AND TRAINING IMPACT

Through over 75 national and international lectures and 10 years of university teaching, Dr. Mohamed M. Abdel-Rahim has transformed aquaculture education in Egypt and abroad. His curriculum covers fish hatchery management, marine aquaculture systems, and environmental engineering, with a strong emphasis on biosafety—a core element in zoonosis control. He has taught and developed more than ten specialized aquaculture courses across Alexandria, Kafrelsheikh, and Suez Canal Universities, including postgraduate programs in fish disease management and hatchery design. Internationally, he has trained scientists in Senegal, South Africa, and other African countries under African Union projects like ITACA, sharing practical skills and theoretical knowledge to bolster regional aquaculture resilience against zoonotic threats. His commitment to capacity building is evident in his supervision of 23 master’s and PhD theses, many of which address water quality, disease resistance, and biosecurity. By emphasizing preventive practices and sustainable systems, he nurtures a new generation of scientists equipped to face the rising zoonotic risks tied to aquatic food production. His work bridges the gap between education, practice, and global health, empowering students and professionals to create safer, healthier aquaculture ecosystems worldwide.

🧬 ZOONOSIS PREVENTION THROUGH AQUACULTURE SYSTEMS

In Dr. Abdel-Rahim’s extensive aquaculture research, zoonosis prevention is not an afterthought—it is a structural priority. His pioneering application of recirculating and integrated aquaculture systems directly contributes to reducing disease transmission across species boundaries, a vital measure in managing zoonotic threats. These systems, particularly his solar-powered R-IMTA model, are designed to enhance water quality, reduce pathogen loads, and minimize human exposure to harmful aquatic pathogens. His work on bioremediation—using probiotics, natural zeolites, and medicinal plants—improves not only fish performance but also public health safety. His studies on feed additives like saponins, nucleotides, and bentonite highlight how tailored nutrition can strengthen fish immunity and reduce the need for antibiotics, a key factor in controlling antimicrobial resistance—another zoonosis-related concern. Dr. Abdel-Rahim’s scientific contributions propose real-world solutions that address both aquaculture productivity and emerging public health risks. His integrated approach ensures that aquaculture is not just economically viable, but also ecologically sound and safe for human consumption. This makes his research a cornerstone in the global effort to understand and prevent aquatic-based zoonoses, especially in the face of increasing demand for fish protein and the intensification of fish farming practices.

🏆 HONORS, PUBLICATIONS, AND GLOBAL RECOGNITION

Dr. Mohamed M. Abdel-Rahim’s distinguished career is adorned with awards, global lectures, and editorial roles, underscoring his position as a world leader in aquaculture and zoonosis-aware research. He has published in more than 50 peer-reviewed journals, many in Q1-ranked outlets such as Aquaculture, Scientific Reports, and Aquaculture International, often addressing immune responses, water quality, and aquafeed innovations—all key to reducing zoonotic threats in fish production. With multiple roles as a journal reviewer and editorial board member for esteemed publications, including PLOS ONE, Marine Drugs, and Journal of Cleaner Production, he influences global research quality and direction. His H-index, tracked across Web of Science, Scopus, and Google Scholar, reflects the scientific weight of his contributions. He has delivered impactful presentations across Africa and Europe, notably at the UN Environment-MED POL regional working groups and African Union conferences. These platforms have enabled him to advocate for sustainable, biosecure aquaculture systems that prioritize public health. Whether supervising PhD candidates or guiding governmental policy discussions, Dr. Abdel-Rahim's accolades reflect his unwavering commitment to science, sustainability, and zoonotic disease prevention.

🌍 IMPACT ON SUSTAINABLE AQUACULTURE DEVELOPMENT

Dr. Abdel-Rahim’s impact on sustainable aquaculture in Egypt and beyond is deeply rooted in his implementation of technologies that align environmental stewardship with public health, particularly in mitigating zoonosis. As a former director and scientific supervisor at El-Max Station for Applied Research, he championed eco-innovative farming practices, integrating marine hatcheries with IMTA models to ensure minimal waste, disease containment, and species welfare. His feasibility studies for international aquaculture investments prioritize biosecurity and environmental harmony, advocating integrated solutions for shrimp, fish, and bivalves farming. His consultancies with companies like Silk Stevens Ltd. and Evergreen United exemplify his ability to bridge academic insight with commercial application, ensuring that food systems remain productive without increasing zoonotic exposure. He routinely collaborates with policymakers and environmental agencies to design training programs that embed principles of biosafety and zoonotic surveillance into national aquaculture strategies. Through his cross-sectoral efforts, Dr. Abdel-Rahim has become a pivotal figure in harmonizing productivity with ecological balance—advancing aquaculture not only as a food system but as a public health safeguard in the face of climate change and emerging zoonotic diseases.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Mohamed M. Abdel-Rahim’s legacy is one of foresight, resilience, and a steadfast commitment to integrating zoonosis prevention into every facet of aquaculture. With over three decades of scientific and educational experience, his blueprint for the future focuses on interdisciplinary collaborations and next-generation aquaculture systems that actively mitigate zoonotic risks. His future contributions aim to enhance molecular-level monitoring of pathogens, apply artificial intelligence to aquaculture biosurveillance, and expand the role of nutraceuticals in fish diets to reduce antibiotic dependence. His ongoing supervision of PhD and master’s theses ensures continuity in research that bridges ecological sustainability with public health. Through expanding training programs, he seeks to arm future scientists with the tools necessary to respond to pandemics that may emerge from aquatic environments. Furthermore, Dr. Abdel-Rahim envisions regional centers of excellence in North Africa for zoonosis monitoring in aquaculture, capitalizing on Egypt’s strategic position in global fish trade. His work is a testament to the principle that aquaculture, when responsibly managed, can be a frontline defense against zoonotic spillovers—reinforcing his enduring influence on both science and society.

NOTABLE PUBLICATION

  • Title: Replacing fishmeal with Palaemon serratus meal enhances growth, carcass traits, digestive enzymes, immune-physiological response, antioxidants, and inner organ histopathology of Dicentrarchus labrax
    Authors: Toqa S. M. Saif, Hatem H. Mahmoud, Ashraf I. G. Elhetawy, Reda M. Fahim, Hosam E. Elsaied, Mohamed M. Abdel-Rahim
    Journal: Aquaculture International
    Publication Date: October 2025

 

  • Title: Correction to: The effect of aqueous application of probiotics on growth, heavy metal accumulation, blood biochemistry, and histological alterations of Dicentrarcus labrax
    Authors: Mohamed M. Abdel‑Rahim, Shimaa A. Shahin, Abdallah Tageldein Mansour, Ahmed Saud Alsaqufi, Ahmed E. Elshafey, Amira A. Omar, Hassan A. El‑Sharkawy, Radi A. Mohamed, Ashraf I. G. Elhetawy
    Journal: Aquaculture International
    Publication Date: June 2025

 

  • Title: Integrated aquaculture of whiteleg shrimp Litopenaeus vannamei and European seabass Dicentrarchus labrax: impacts on performance, welfare, blood physiological response, carcass traits, productivity, and farm profitability
    Authors: Ashraf I. G. Elhetawy, Abdallah Tageldein Mansour, Ayman M. Lotfy, Ahmed I. A. Mansour, Shimaa A. Shahin, Mohamed M. Zayed, Ghada R. Sallam, Mohamed M. Abdel-Rahim
    Journal: Aquaculture International
    Publication Date: June 2025

 

  • Title: The effect of aqueous application of probiotics on growth, heavy metal accumulation, blood biochemistry, and histological alterations of Dicentrarcus labrax
    Authors: Mohamed M. Abdel-Rahim, Shimaa A. Shahin, Abdallah Tageldein Mansour, Ahmed Saud Alsaqufi, Ahmed E. Elshafey, Amira A. Omar, Hassan A. El-Sharkawy, Radi A. Mohamed, Ashraf I. G. Elhetawy
    Journal: Aquaculture International
    Publication Date: April 2025

 

  • Title: Effect of the bipolar aluminum electrocoagulation model (BAEM) on heavy metal concentration, growth, immunological response, and parasitic activity in cultured Dicentrarchus labrax in underground seawater
    Authors: Amr Fadel, Abeer A. Moneer, Khaled M. Abdelsalam, Mohamed M. Abdel-Rahim
    Journal: Aquaculture
    Publication Date: April 8, 2025